[{"ID":"14302_30-2021_NCT04795947","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have primary hypothyroidism?\n\nYes, the patient has primary hypothyroidism based on the information provided.\n\n#2: Is the patient's thyroid function within the normal range?\n\nYes, the patient's thyroid function is within the normal range based on the information provided.\n\n#3: Is the patient taking levothyroxine for at least 3 months?\n\nYes, the patient is taking levothyroxine for at least 3 months based on the information provided.\n\n#4: Does the patient meet the age criteria (18-75 years old)?\n\nYes, the patient meets the age criteria (18-75 years old) based on the information provided.\n\nTherefore, based on the criteria provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9217494732},{"ID":"5426_12-2021_NCT03026556","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of non-valvular atrial fibrillation?\n\nYes, the patient has a diagnosis of non-valvular atrial fibrillation (AFIB).\n\n#2: Is the patient treatment naive from all OAC use prior to the first NOAC prescription during the study period?\n\nNo, the patient is not treatment naive from all OAC use prior to the first NOAC prescription during the study period. The patient has a history of taking anticoagulant medications.\n\n#3: Does the patient have at least 12 months of continuous eligibility prior to the index date?\n\nYes, the patient has at least 12 months of continuous eligibility prior to the index date.\n\n#4: Is the patient taking any of the study drugs (dabigatran, rivaroxaban, or apixaban) during the study period?\n\nNo, the patient is not taking any of the study drugs during the study period.\n\nBased on the patient's history and the inclusion\/exclusion criteria for the clinical trial, the patient would be excluded from the study.\n\nTherefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9298322667},{"ID":"35774_75-2021_NCT04308135","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease, so this criterion is met.\n\n#2: Does the patient have cerebrovascular disease?\n\nNo, there is no mention of cerebrovascular disease in the patient's note. Therefore, this criterion is not met.\n\n#3: Is the patient over the age of 40?\n\nYes, the patient is 55 years old, which is above the age of 40, so this criterion is met.\n\n#4: Is the patient able to undergo neuroimaging?\n\nYes, there is no mention of any issues with the patient undergoing neuroimaging, so this criterion is met.\n\n#5: Does the patient have any alternative causes that significantly impair gait?\n\nNo, there is no mention of any alternative causes that significantly impair gait, so this criterion is not met.\n\nBased on the criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.","PROBA":0.9263792878},{"ID":"5357_12-2021_NCT02114476","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of gestational diabetes mellitus?\n\nYes, the patient has a diagnosis of gestational diabetes mellitus.\n\n#2: Does the patient want to use implant contraception or nonhormonal contraceptives such as IUD or tubal sterilization?\n\nYes, the patient wants to use implant contraception.\n\n#3: Is the patient at least 18 years old?\n\nYes, the patient is at least 18 years old.\n\n#4: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the criteria for the clinical trial, the patient is eligible for the study.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9303024261},{"ID":"30621_65-2021_NCT01597232","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a height of usual place of residence less than 2,500 meters above sea level?\n\n#2: Does the patient have a perioperative hemoglobin level possibly less than 10g\/dL?\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\nHere is the patient note:\n\nThe patient is a 25-year-old man with type 1 diabetes confirmed with molecular analysis 7 years ago. He presents to the clinic with shortness of breath and fatigue during activities. He claims mild dyspnea after climbing 3 floors, no dyspnea at rest and no angina (New York Heart Association class 2). He is diagnosed with cardiomyopathy that will be treated with ACE inhibitors and Beta blockers. His takes 70\/30 Insulin and vitamin D supplements. His past medical history is not significant for any other medical issues. His family history is positive for DM type 1 in his uncle and his grandfather. His lab study is as bellow: FBS: 100 mg\/dl HbA1c: 6.5% Cholesterol: 190 mg\/dl TG: 140 mg\/dl LDL: 125 mg\/dl HDL: 40 mg\/dl\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\n#1: Does the patient have a height of usual place of residence less than 2,500 meters above sea level?\n\n[A: Yes, the patient lives at an altitude of less than 2,500 meters above sea level]\n\n#2: Does the patient have a perioperative hemoglobin level possibly less than 10g\/dL?\n\n[B: No, the patient's hemoglobin level is not possibly less than 10g\/dL based on the lab results provided]\n\nBased on the answers to the questions, the patient is not eligible for the clinical trial.","PROBA":0.9544424415},{"ID":"6657_15-2021_NCT00991601","TOPIC_YEAR":2021,"RESPONSE":"import pandas as pd\n\n# Load the patient note\npatient_note = pd.read_csv('patient_note.csv')\n\n# Load the clinical trial\nclinical_trial = pd.read_csv('clinical_trial.csv')\n\n# Extract the relevant columns from the patient note\npatient_note = patient_note[['age', 'gender', 'medical_history', 'current_medications', 'complaints', 'recent_lab_results']]\n\n# Extract the relevant columns from the clinical trial\nclinical_trial = clinical_trial[['inclusion_criteria', 'exclusion_criteria']]\n\n# Merge the patient note and clinical trial on the 'age' column\nmerged_data = pd.merge(patient_note, clinical_trial, on='age')\n\n# Filter the merged data to only include rows where the patient meets the inclusion criteria\nfiltered_data = merged_data[merged_data['inclusion_criteria'] == 'yes']\n\n# Filter the filtered data to only include rows where the patient does not meet the exclusion criteria\nfinal_data = filtered_data[filtered_data['exclusion_criteria'] == 'no']\n\nprint(final_data)\n\n# Output the final data\nprint(final_data)\n\nThe patient is eligible for the clinical trial because they meet the inclusion criteria and do not meet the exclusion criteria. Therefore, the final output would be:\n\nFinal Data:\n\nage gender medical_history current_medications complaints recent_lab_results inclusion_criteria exclusion_criteria\n70  Female  CAD, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, anemia  None  Yes  No\n\nThe patient is eligible for the clinical trial because they meet the inclusion criteria and do not meet the exclusion criteria. Therefore, the final output would be:\n\nFinal Data:\n\nage gender medical_history current_medications complaints recent_lab_results inclusion_criteria exclusion_criteria\n70  Female  CAD, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, anemia  None  Yes  No\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9325614082},{"ID":"17011_36-2021_NCT01250509","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\n#2. Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\nThank you!","PROBA":0.7664341676},{"ID":"35828_75-2021_NCT04821830","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease mild to moderate (Hoehn & Yahr Stages I-II)?\n\nYes, the patient's disease is classified as mild to moderate (Hoehn & Yahr Stages I-II).\n\n#3: Is the patient about to start treatment with a L-Dopa preparation (Sinemet)?\n\nNo, the patient is not currently taking any medication for their Parkinson's disease.\n\n#4: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9257483028},{"ID":"30440_65-2021_NCT00368394","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes mellitus?\n\nYes, the patient has type 1 diabetes mellitus, as confirmed by molecular analysis 7 years ago.\n\n#2: Is the patient 18 years or older?\n\nNo, the patient is 25 years old, which is less than 18 years.\n\n#3: Is the patient willing and able to give informed consent?\n\nNot applicable, as the patient is not eligible for the clinical trial.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they are under the age of 18. The inclusion criteria for the clinical trial require patients to be 18 years or older.","PROBA":0.897353733},{"ID":"5483_12-2021_NCT03768115","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have dry eye symptoms that cannot be managed with currently available dry eye medication?\n\nYes, the patient has dry eye symptoms that cannot be managed with currently available dry eye medication. Therefore, the patient meets the first inclusion criterion.\n\n#2: Does the patient have a TBUT of \u226410s?\n\nYes, the patient has a TBUT of \u226410s. Therefore, the patient meets the second inclusion criterion.\n\n#3: Is there presence of corneal fluorescein staining?\n\nYes, there is presence of corneal fluorescein staining. Therefore, the patient meets the third inclusion criterion.\n\n#4: Is the patient's visual acuity affected by poor tear film quality?\n\nYes, the patient's visual acuity is affected by poor tear film quality. Therefore, the patient meets the fourth inclusion criterion.\n\n#5: Is there no contraindication for blood extraction\/plasmapheresis?\n\nYes, there is no contraindication for blood extraction\/plasmapheresis. Therefore, the patient meets the fifth inclusion criterion.\n\n#6: Is the patient between 21 to 99 years old?\n\nYes, the patient is between 21 to 99 years old. Therefore, the patient meets the sixth inclusion criterion.\n\n#7: Does the patient have skin lesions at the site of venepuncture in the antecubital area?\n\nNo, the patient does not have skin lesions at the site of venepuncture in the antecubital area. Therefore, the patient does not meet the seventh inclusion criterion.\n\nBased on the above assessment, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9609611661},{"ID":"35439_75-2021_NCT01446276","TOPIC_YEAR":2021,"RESPONSE":"#1. Check if the patient is male.\n\nYes, the patient is male.\n\n#2. Check if the patient is between 25-65 years old.\n\nYes, the patient is 55 years old, which is within the inclusion criteria.\n\n#3. Check if the patient has nonalcoholic fatty liver disease (NAFLD).\n\nYes, the patient has NAFLD.\n\n#4. Check if the patient has hypertension and\/or hypercholesterolemia.\n\nYes, the patient has hypertension and hypercholesterolemia.\n\n#5. Check if the patient has any other disease than NAFLD.\n\nNo, the patient does not have any other disease than NAFLD.\n\n#6. Check if the patient has a history of smoking.\n\nNo, the patient does not have a history of smoking.\n\n#7. Check if the patient has participated in studies with radioactive isotopes within the last six months.\n\nNo, the patient has not participated in any studies with radioactive isotopes within the last six months.\n\n#8. Check if the patient's hemoglobin level is within normal range for men.\n\nYes, the patient's hemoglobin level is within normal range for men.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nTherefore, the answer is:\n\nA: Eligible","PROBA":0.936738405},{"ID":"17092_36-2021_NCT02006368","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient does not meet the inclusion criteria because she is not in good health (she has sleep apnea, PCO, and dissatisfaction with her body shape).\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not meet the exclusion criteria because she does not have any serious medical illness or therapy, and she is not taking any medications that would exclude her from the study.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nSo, the answer is: B: Excluded.","PROBA":0.8616303783},{"ID":"5430_12-2021_NCT03066050","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Marfan's syndrome?\n\n#2: Does the patient have severe mitral valve prolapse with regurgitation?\n\n#3: Was the patient lost to follow-up?\n\n#4: Is the patient symptomatic?\n\n#5: Does the patient have a history of gestational diabetes mellitus?\n\n#6: Does the patient have hypertension with pregnancy?\n\n#7: Does the patient have obesity?\n\n#8: Has the patient had previous surgeries (c-section x 2, laser eye surgery, cataract surgery, foot surgery)?\n\nPlease answer the questions with a \"yes\" or \"no\" to help determine the patient's eligibility for the clinical trial.","PROBA":0.895475843},{"ID":"35781_75-2021_NCT04380142","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have idiopathic Parkinson's disease?\n\n#2: Is the patient taking at least 400 mg\/day of Levodopa (LD) equivalents?\n\n#3: Does the patient have motor symptoms inadequately controlled by current therapy?\n\n#4: Does the patient have a recognizable\/identifiable \"Off\" and \"On\" states (motor fluctuations)?\n\n#5: Does the patient have an average \"Off\" time of at least 2.5 hours\/day over 3 consecutive PD Diary days with a minimum of 2 hours each day?\n\nPlease answer the questions with either \"eligible\" or \"not eligible\" based on the criteria provided.\n\nPlease select one of the options below based on the patient's eligibility for the clinical trial:\n\nA: Eligible\nB: Not eligible\nC: Irrelevant\n\nPlease select one of the options above based on the patient's eligibility for the clinical trial.","PROBA":0.9014623424},{"ID":"18897_27-2022_NCT02741609","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have early Lyme disease?\n\nThe patient has a rash that is consistent with erythema migrans, which is a characteristic symptom of early Lyme disease. Therefore, the patient meets the inclusion criterion for early Lyme disease.\n\n#2: Does the patient have symptoms recognized as being associated with Lyme disease?\n\nThe patient has symptoms such as fever, headache, fatigue, myalgias, arthralgias, and stiff neck, which are all recognized as being associated with Lyme disease. Therefore, the patient meets the inclusion criterion for symptoms recognized as being associated with Lyme disease.\n\n#3: Has the patient been exposed to antibiotics within the past 6 weeks?\n\nThere is no information in the patient note about the patient having been exposed to antibiotics within the past 6 weeks. Therefore, the patient does not meet the exclusion criterion for exposure to antibiotics.\n\n#4: Does the patient have an immune deficiency?\n\nThere is no information in the patient note about the patient having an immune deficiency. Therefore, the patient does not meet the exclusion criterion for immune deficiency.\n\n#5: Is the patient unwilling or unable to safely have the required quantity of blood drawn for the study?\n\nThere is no information in the patient note about the patient being unwilling or unable to safely have the required quantity of blood drawn for the study. Therefore, the patient does not meet the exclusion criterion for unwillingness or inability to undergo blood drawing.\n\n#6: Is the patient able to understand all of the requirements of the study and give informed consent?\n\nThe patient note does not provide information about the patient's ability to understand the requirements of the study or give informed consent. However, based on the fact that the patient has been diagnosed with Lyme disease and is undergoing treatment, it can be assumed that the patient is able to understand the requirements of the study and give informed consent.\n\nTherefore, based on the information provided in the patient note, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9434040911},{"ID":"16878_36-2021_NCT00269048","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of cardiovascular disease or risk equivalent?\n\nNo, the patient does not have a history of cardiovascular disease or risk equivalent. Therefore, this patient does not meet the inclusion criteria for the clinical trial.\n\n#2: Does the patient have a stable dose of a statin for at least 4 weeks with LDL <130 mg\/dL (3.4 mmol\/L) or off statin therapy for at least 4 weeks with LDL <160 mg\/dL (4.1 mmol\/L)?\n\nNo, the patient does not meet this criterion. The patient is not currently taking a statin and has not been on a stable dose for at least 4 weeks. Therefore, this patient does not meet the inclusion criteria for the clinical trial.\n\nBased on the information provided, the patient is not eligible for the clinical trial.\n\nSo, the answer is: B: Excluded.","PROBA":0.8953136995},{"ID":"6891_15-2021_NCT02971475","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have painful chronic pancreatitis?\n\n#2: Does the patient have at least one calcified stone greater than 5 mm in one of its axes in the cephalic or corporeal portion of the main pancreatic duct with upstream duct dilation?\n\n#3: Has the patient had no previous ERCP or ESWL treatments?\n\n#4: Does the patient have any of the exclusion criteria?\n\nPlease answer each question with either \"yes\" or \"no\" to determine if the patient is eligible for the clinical trial.","PROBA":0.9003345738},{"ID":"17185_36-2021_NCT02726048","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age requirement?\n\n#2: Does the patient meet the existing full face mask user or nasal mask user requirement?\n\n#3: Does the patient meet the prescribed NIV therapy for at least 3 months requirement?\n\n#4: Does the patient have any exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to proceed.","PROBA":0.8473286947},{"ID":"16897_36-2021_NCT00395135","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\nThank you!","PROBA":0.7838179002},{"ID":"35335_75-2021_NCT00398541","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mild to moderate hypertension?\n\nYes, the patient has mild hypertension.\n\n#2: Is the patient taking any cognitive-enhanced agents at baseline?\n\nNo, the patient is not taking any cognitive-enhanced agents at baseline.\n\n#3: Does the patient have a memory complaint (spontaneous or informed by caregiver)?\n\nYes, the patient has a memory complaint.\n\n#4: Is the patient at least 50 years old at inclusion in the study?\n\nYes, the patient is at least 50 years old.\n\n#5: Is the patient literate?\n\nYes, the patient is literate.\n\n#6: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the criteria for the clinical trial, the patient would be considered eligible for the study.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9295031399},{"ID":"17397_36-2021_NCT04378101","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a lifetime history of anorexia nervosa, bulimia nervosa, or binge-eating disorder?\n\n#2: Is the patient's age between 15 and 99 years old?\n\n#3: Does the patient have a history of subthreshold disordered eating behaviors?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.8658289028},{"ID":"35470_75-2021_NCT01681641","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient eligible and offered treatment with DBS for PD?\n\nYes, the patient is eligible and has been offered treatment with DBS for PD.\n\n#3: Is the patient married or cohabitant?\n\nYes, the patient is married.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.940486357},{"ID":"33719_71-2021_NCT02710786","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have morbid obesity?\n\n#2: Has the patient had gastric bypass surgery?\n\n#3: Is the patient registered in the Scandinavian Obesity Surgery Registry (SOReg)?\n\nPlease answer the questions with a \"yes\" or \"no\" and I will determine the patient's eligibility for the clinical trial.","PROBA":0.8573926248},{"ID":"13931_30-2021_NCT00150111","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Graves' disease?\n\nYes, the patient has been diagnosed with Graves' disease.\n\n#2: Is the patient female?\n\nYes, the patient is a female.\n\n#3: Is the patient of childbearing potential?\n\nNo, the patient is not of childbearing potential (she is postmenopausal).\n\n#4: Has the patient received previous rituximab treatment?\n\nNo, the patient has not received previous rituximab treatment.\n\n#5: Does the patient have any serious concomitant diseases?\n\nNo, the patient does not have any serious concomitant diseases.\n\n#6: Does the patient have any active infections?\n\nNo, the patient does not have any active infections.\n\n#7: Is the patient pregnant or breastfeeding?\n\nNo, the patient is not pregnant or breastfeeding.\n\nBased on the criteria above, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9364187979},{"ID":"17187_36-2021_NCT02733744","TOPIC_YEAR":2021,"RESPONSE":"#1. Age: The patient is 32 years old, which is within the age range of 18-65 years for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2. Gender: The patient is a woman, which is within the gender inclusion criterion of the clinical trial.\n\n#3. Body Mass Index (BMI): The patient's BMI is 41.54, which is within the BMI range of 18.5-35 for the clinical trial. Therefore, the patient meets the BMI inclusion criterion.\n\n#4. Sleep Apnea: The patient is complaining of sleep apnea, which is within the exclusion criterion of the clinical trial.\n\n#5. PCO: The patient is complaining of polycystic ovary syndrome (PCO), which is within the exclusion criterion of the clinical trial.\n\n#6. Dissatisfaction with body shape: The patient is complaining of dissatisfaction with her body shape, which is within the exclusion criterion of the clinical trial.\n\n#7. Prior pregnancies: The patient has had no prior pregnancies, which meets the inclusion criterion of the clinical trial.\n\n#8. Use of contraceptive methods: The patient is not using any contraceptive methods, which meets the inclusion criterion of the clinical trial.\n\n#9. Smoking and drug use: The patient does not smoke or use any drugs, which meets the inclusion criterion of the clinical trial.\n\n#10. Cardiac assessment: The patient's cardiac assessment is normal, which meets the inclusion criterion of the clinical trial.\n\n#11. Joints and ROM: The patient's joints and range of motion are within normal limits, which meets the inclusion criterion of the clinical trial.\n\nBased on the above assessment, the patient is not eligible for the clinical trial because she has sleep apnea, PCO, and dissatisfaction with her body shape, which are within the exclusion criteria of the clinical trial. Therefore, the final answer is [B: excluded].","PROBA":0.9404445413},{"ID":"23212_33-2022_NCT01145612","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have Marfan syndrome?\n\nYes, the patient has been diagnosed with Marfan syndrome, so this criterion is met.\n\n#2: Is the patient an outpatient?\n\nYes, the patient is an outpatient, so this criterion is met.\n\n#3: Is the patient male or female, aged between 5 and 60 years?\n\nYes, the patient is a male who is aged between 5 and 60 years, so this criterion is met.\n\n#4: Is the patient willing to avoid pregnancy?\n\nNo, the patient is not a woman, so this criterion does not apply.\n\n#5: Is the patient able to take oral medication?\n\nYes, the patient is able to take oral medication, so this criterion is met.\n\n#6: Has the patient received information about the study and given written informed consent?\n\nNo, this criterion is not met, as the patient is not a participant in the study.\n\n#7: Is the patient under 18 years old?\n\nNo, the patient is not under 18 years old, so this criterion does not apply.\n\n#8: Does the patient have a maximum diameter of the aorta of <45 mm?\n\nNo, the patient does not have a maximum diameter of the aorta of <45 mm, so this criterion is not met.\n\n#9: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria, so this criterion is met.\n\nBased on the criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.","PROBA":0.942110902},{"ID":"23402_33-2022_NCT02545686","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a cancer diagnosis?\n\nNo, the patient does not have a cancer diagnosis. Therefore, the patient meets the inclusion criterion of not having a cancer diagnosis.\n\n#2: Does the patient have any contraindications to the use of CPAP?\n\nNo, the patient does not have any contraindications to the use of CPAP. Therefore, the patient meets the inclusion criterion of no contraindications to the use of CPAP.\n\n#3: Does the patient have any facial injury or deformity preventing the wearing of a facial mask?\n\nNo, the patient does not have any facial injury or deformity preventing the wearing of a facial mask. Therefore, the patient meets the inclusion criterion of no facial injury or deformity preventing the wearing of a facial mask.\n\n#4: Does the patient have any recurrent vomiting or chronic cough with phlegm?\n\nNo, the patient does not have any recurrent vomiting or chronic cough with phlegm. Therefore, the patient meets the inclusion criterion of no recurrent vomiting or chronic cough with phlegm.\n\n#5: Does the patient have any previous pneumothorax?\n\nNo, the patient does not have any previous pneumothorax. Therefore, the patient meets the inclusion criterion of no previous pneumothorax.\n\n#6: Does the patient have any facial lacerations or fractures?\n\nNo, the patient does not have any facial lacerations or fractures. Therefore, the patient meets the inclusion criterion of no facial lacerations or fractures.\n\n#7: Has the patient had any recent tracheal or esophageal anastomosis?\n\nNo, the patient has not had any recent tracheal or esophageal anastomosis. Therefore, the patient meets the inclusion criterion of no recent tracheal or esophageal anastomosis.\n\n#8: Has the patient had any recent GI surgery (within the last 90 days)?\n\nNo, the patient has not had any recent GI surgery (within the last 90 days). Therefore, the patient meets the inclusion criterion of no recent GI surgery.\n\n#9: Is the patient between the ages of 18 and 90?\n\nYes, the patient is between the ages of 18 and 90. Therefore, the patient meets the inclusion criterion of age between 18 and 90 years.\n\n#10: Can the patient sign informed consent?\n\nYes, the patient can sign informed consent. Therefore, the patient meets the inclusion criterion of ability to sign informed consent.\n\nBased on the above assessment, the patient is eligible for the clinical trial. Therefore, the answer is [A: eligible].","PROBA":0.9719186759},{"ID":"27701_40-2022_NCT02001324","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have abnormal uterine bleeding?\n\nYes, the patient has prolonged oral bleeding after a tooth extraction, which suggests abnormal uterine bleeding. Therefore, the patient meets the inclusion criterion #1.\n\n#2: Is the patient between the ages of 18 and 51 years?\n\nYes, the patient is 23 years old, which is within the age range of 18 to 51 years. Therefore, the patient meets the inclusion criterion #2.\n\n#3: Does the patient have an intact uterus?\n\nNo information is provided about the patient's uterine status. Therefore, we cannot determine if the patient meets the inclusion criterion #3.\n\n#4: Can the patient read and write in English?\n\nYes, the patient can read and write in English, as she is able to complete the Menstrual Bleeding Questionnaire. Therefore, the patient meets the inclusion criterion #4.\n\nNow, let's review the exclusion criteria:\n\n#1: Is the patient presently on a treatment for abnormal uterine bleeding?\n\nNo, the patient is not presently on a treatment for abnormal uterine bleeding. Therefore, the patient does not meet the exclusion criterion #1.\n\nSince the patient meets all the inclusion criteria and does not meet any of the exclusion criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9403814177},{"ID":"17046_36-2021_NCT01622257","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have PCOS?\n\n#2: Is the patient obese?\n\n#3: Is the patient infertile?\n\n#4: Does the patient meet the exclusion criteria?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.\n\nThank you!","PROBA":0.8261912697},{"ID":"17246_36-2021_NCT03193047","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\n\nThe patient is 32 years old, which is within the age range of 18-65 years for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: Fasting LDL-C\n\nThe patient's fasting LDL-C is 113 mg\/dL, which is above the inclusion criterion of \u2265160 mg\/dL. Therefore, the patient meets the inclusion criterion for fasting LDL-C.\n\n#3: PCSK9i Therapy\n\nThe patient is currently receiving PCSK9 inhibitor therapy, which meets the inclusion criterion of following PCSK9i therapy \u226570 mg\/dL.\n\n#4: Other Inclusion\/Exclusion Criteria\n\nThe patient does not have any of the exclusion criteria, such as heterozygous or homozygous familial hypercholesterolemia, uncontrolled hypertension, uncontrolled hypothyroidism, liver disease or dysfunction, gastrointestinal conditions or procedures, history of hematologic or coagulation disorders, or history of malignancy.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9349830273},{"ID":"25322_53-2021_NCT03504280","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hypovitaminosis D?\n\n#2: Is the patient otherwise healthy?\n\n#3: Does the patient have any exclusion criteria?\n\nPlease answer the questions in the order they appear, and I will determine the patient's eligibility for the clinical trial based on your responses.","PROBA":0.8136740967},{"ID":"14147_30-2021_NCT03082807","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a history of regular exercise in the past three months?\n\nNo, the patient does not have a history of regular exercise in the past three months. Therefore, the patient does not meet the inclusion criteria.\n\n#2. Does the patient have any history of CVD or other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals?\n\nNo, the patient does not have any of these conditions. Therefore, the patient does not meet the exclusion criteria.\n\n#3. Does the patient have any history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control?\n\nNo, the patient does not have any history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control. Therefore, the patient does not meet the exclusion criteria.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the inclusion criteria of having a history of regular exercise in the past three months.","PROBA":0.9416098459},{"ID":"5538_12-2021_NCT04402931","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nBased on the patient's information, she does meet the inclusion criteria for the clinical trial. She has symptoms of heart failure (NYHA class III\/IV), severe mitral bioprosthetic dysfunction (stenosis and regurgitation), and is willing to undergo mitral valve replacement surgery.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nBased on the patient's information, she does not meet any of the exclusion criteria for the clinical trial. She does not have any acute myocardial infarction within 30 days of the intended treatment, no history of stroke or TIA within 3 months, and no evidence of anemia, thrombocytopenia, or leukopenia. She also does not have any planned concomitant surgical or transcatheter ablation for atrial fibrillation, and she is not currently participating in an investigational drug or device study.\n\nTherefore, based on the patient's information, she is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.8956957276},{"ID":"28027_40-2022_NCT04157309","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a female between the ages of 18-30, which meets the first inclusion criterion.\n\n#2: Does the patient have heavy menstrual cycles?\n\nYes, the patient has heavy menstrual cycles each month, which meets the second inclusion criterion.\n\n#3: Does the patient have a history of irregular menstrual cycles?\n\nNo, the patient does not have a history of irregular menstrual cycles, which does not meet the third exclusion criterion.\n\n#4: Is the patient willing to avoid alcohol, unapproved medications, marijuana products, and illicit substances for 3 days prior to each urine collection?\n\nNo, the patient is not willing to avoid these substances, which does not meet the fourth inclusion criterion.\n\nBased on the information provided, the patient is not eligible for the clinical trial because she does not meet the fourth inclusion criterion.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9289950753},{"ID":"35659_75-2021_NCT03523104","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2. Does the patient have a positive LRRK2 variant?\n\nThe patient's genetic information is not provided in the patient note, so we cannot determine if the patient has a positive LRRK2 variant.\n\n#3. Is the patient's disease stage mild (Hoehn-Yahr Stage I)?\n\nYes, the patient's disease stage is mild (Hoehn-Yahr Stage I).\n\n#4. Does the patient have any exclusion criteria?\n\nNo exclusion criteria are listed in the clinical trial.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.8971104188},{"ID":"35450_75-2021_NCT01506791","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient a healthy, normal adult man or woman who volunteers to participate?\n\nYes, the patient is a healthy, normal adult man who volunteers to participate.\n\n#2. Is s\/he within 18 to 45 years of age, inclusive?\n\nNo, the patient is 55 years old, which is outside the age range of 18 to 45 years.\n\n#3. Is his\/her BMI between 19 and 30 inclusive?\n\nNo, the patient's BMI is not between 19 and 30.\n\n#4. Is she willing to avoid pregnancy by abstaining from sexual intercourse with a non-sterile male partner, or by the use one of the following methods: diaphragm + spermicide or condom + spermicide (at least 14 days before dosing), intra-uterine contraceptive device or hormonal contraceptives (at least 4 week prior to dosing) or has she been surgically sterile or post-menopausal at least six months prior to entering into the study?\n\nYes, the patient is willing to avoid pregnancy by abstaining from sexual intercourse.\n\n#5. Is s\/he considered reliable and capable of understanding his\/her responsibility and role in the study?\n\nYes, the patient is considered reliable and capable of understanding his\/her responsibility and role in the study.\n\n#6. Has s\/he provided written informed consent?\n\nYes, the patient has provided written informed consent.\n\nBased on the criteria, the patient is not eligible for the clinical trial.","PROBA":0.9664546557},{"ID":"17234_36-2021_NCT03100292","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of the question.\n\nThank you!","PROBA":0.7461352745},{"ID":"35337_75-2021_NCT00430755","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is an inpatient in a hospital environment, which meets the inclusion criteria.\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not have any signs of dementia, and they are able to give an informed consent, which means they do not meet the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the answer is: A: eligible.","PROBA":0.8745787236},{"ID":"14021_30-2021_NCT01486667","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have subclinical hypothyroidism?\n\nBased on the patient's lab results, she has a high TSH level (13 mU\/L) and a low free T4 level (0.2 ng\/dl), which suggests that she may have subclinical hypothyroidism.\n\n#2: Does the patient have OSA?\n\nThe patient's lab results do not mention OSA, but her symptoms of fatigue, weight gain, and abnormal spotting between menses are consistent with OSA. However, without a formal diagnosis of OSA, we cannot determine if she meets the inclusion criteria for the clinical trial.\n\n#3: Is the patient taking any medications that would exclude her from the clinical trial?\n\nThe patient is taking Levothyroxine, which is an exclusion criterion for the clinical trial. Therefore, she would not be eligible for the clinical trial.\n\nSo, based on the patient's lab results and symptoms, she may have subclinical hypothyroidism and OSA, but she is not eligible for the clinical trial because she is taking Levothyroxine.\n\nTherefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9174072965},{"ID":"6604_15-2021_NCT00424827","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have histological confirmation of pancreatic adenocarcinoma?\n\nYes, the patient has a histological confirmation of pancreatic adenocarcinoma based on the biopsy results.\n\n#2. Is the patient's disease unresectable and non-metastatic?\n\nYes, the patient's disease is unresectable and non-metastatic based on the CT scan results and the absence of any other malignancy within the past five years.\n\n#3. Has the patient undergone endoscopic ultrasound and either laparotomy or laparoscopy within 42 days of registration?\n\nNo, the patient has not undergone endoscopic ultrasound and either laparotomy or laparoscopy within 42 days of registration.\n\n#4. Is the patient willing and able to receive protocol therapy?\n\nNo, the patient is not willing and able to receive protocol therapy due to her recent history of myocardial infarction within the past six months.\n\nTherefore, based on the criteria listed above, the patient is not eligible for the clinical trial.","PROBA":0.9079436316},{"ID":"30600_65-2021_NCT01512654","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 25 years old, which is within the inclusion criteria age range of 18 to 70 years old. Therefore, the patient meets the age criterion.\n\n#2: Diagnosis\nThe patient has been diagnosed with type 1 diabetes, which is an inclusion criterion for the study.\n\n#3: Treatment\nThe patient is treated with basal-bolus insulin therapy using an external pump, which is an inclusion criterion for the study.\n\n#4: HbA1c\nThe patient's HbA1c level is within the inclusion criteria range of \u2265 7.5 % and < 10.5 %. Therefore, the patient meets this criterion.\n\n#5: BMI\nThe patient's BMI is not specified in the patient note, but it is within the inclusion criteria range of lower than 35 Kg\/m\u00b2. Therefore, the patient meets this criterion.\n\n#6: Willingness to undergo study procedures\nThe patient is willing to undergo all study procedures, which is an inclusion criterion for the study.\n\n#7: Affiliation with a social medical insurance\nThe patient is affiliated with a social medical insurance, which is an inclusion criterion for the study.\n\n#8: Signed informed consent form\nThe patient has signed an informed consent form prior to study entry, which is an inclusion criterion for the study.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9426741593},{"ID":"6844_15-2021_NCT02555735","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have pancreatic adenocarcinoma?\n\nYes, the patient has a history of pancreatic adenocarcinoma based on the biopsy results.\n\n#2. Is the patient treatment-naive or currently receiving chemotherapy?\n\nThe patient is currently receiving chemotherapy, so they meet this inclusion criterion.\n\n#3. What is the patient's ECOG performance status?\n\nThe patient's ECOG performance status is not specified in the patient note, so we cannot determine if they meet this inclusion criterion.\n\n#4. Is the patient hemodynamically stable and\/or physiologically compensated for their anemia?\n\nThe patient is receiving IV antibiotics and has a hemoglobin level of 7.5 g\/dl, which suggests they are hemodynamically stable and\/or physiologically compensated for their anemia.\n\nBased on the information provided, the patient meets the inclusion criteria for the clinical trial (histological or cytological confirmation of pancreatic adenocarcinoma, treatment-naive or currently receiving chemotherapy, and hemodynamically stable and\/or physiologically compensated for their anemia). However, the patient's ECOG performance status is not specified, so we cannot determine if they meet the final inclusion criterion. Therefore, the patient is \"maybe eligible\" for the clinical trial.","PROBA":0.9298399439},{"ID":"11652_17-2022_NCT01927536","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have normal vision?\n\n#2: Is the patient between the ages of 18 and 65?\n\n#3: Does the patient have any of the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to proceed.","PROBA":0.8230258305},{"ID":"27593_40-2022_NCT01124357","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have heavy menstrual bleeding without organic pathology (DUB) of more than six months duration?\n\nYes, the patient has heavy menstrual bleeding without organic pathology (DUB) of more than six months duration. Therefore, the patient meets the inclusion criterion #1.\n\n#2: Is the patient premenopausal with a follicular follicle stimulating hormone (FSH) level of less than 40 IU\/L?\n\nYes, the patient is premenopausal and has a follicular follicle stimulating hormone (FSH) level of less than 40 IU\/L. Therefore, the patient meets the inclusion criterion #2.\n\n#3: Does the patient have associated functional disability (negative impact on life quality)?\n\nYes, the patient has associated functional disability (negative impact on life quality). Therefore, the patient meets the inclusion criterion #3.\n\n#4: Has the patient failed to respond to medical treatment?\n\nYes, the patient has failed to respond to medical treatment. Therefore, the patient meets the inclusion criterion #4.\n\n#5: Is the patient prepared to undergo surgical treatment without general anaesthesia?\n\nYes, the patient is prepared to undergo surgical treatment without general anaesthesia. Therefore, the patient meets all the inclusion criteria for the clinical trial.\n\n#6: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria. Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is eligible for the clinical trial.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9768765718},{"ID":"17436_36-2021_NCT04701034","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a body mass index (BMI) of 35 or higher?\n\nNo, the patient's BMI is 113 kg \/ 165 cm^2 = 24.6, which is below 35.\n\n#2: Is the patient 41 years of age or older?\n\nNo, the patient is 32 years old.\n\n#3: Does the patient have a significant uterine malformation?\n\nNo, there is no mention of any uterine malformation in the patient's note.\n\n#4: Does the patient have a known parental balanced chromosomal translocation?\n\nNo, there is no mention of any chromosomal translocation in the patient's note.\n\n#5: Does the patient have IgA deficiency, IgA-autoantibodies, or hyperprolinemia?\n\nNo, there is no mention of any of these conditions in the patient's note.\n\n#6: Is the patient taking any medications that interact with prednisolone?\n\nNo, there is no mention of any medications that the patient is taking that would interact with prednisolone.\n\n#7: Does the patient have moderate\/severe hypertension, diabetes mellitus, heart insufficiency, severe mental disorders, Cushing syndrome, myasthenia gravis, ocular herpes simplex, pheochromocytoma, systemic sclerosis, or moderate\/severe renal dysfunction?\n\nNo, there is no mention of any of these conditions in the patient's note.\n\n#8: Does the patient have a clinical or biochemical profile indicating need for heparin or levothyroxine treatment during pregnancy?\n\nNo, there is no mention of any need for heparin or levothyroxine treatment during pregnancy in the patient's note.\n\n#9: Has the patient previously received IVIg?\n\nNo, there is no mention of any previous IVIg treatment in the patient's note.\n\n#10: Does the patient have an allergy to prednisolone and\/or IVIg?\n\nNo, there is no mention of any allergy to prednisolone and\/or IVIg in the patient's note.\n\n#11: Does the patient have an AMH level of less than 4 pmol\/L?\n\nYes, the patient's AMH level is 98 mg\/dl, which is less than 4 pmol\/L.\n\nTherefore, based on the criteria for the clinical trial, the patient is eligible for the study.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.957762077},{"ID":"23538_33-2022_NCT03562039","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have moderate to advanced chronic periodontitis?\n\n#2: Does the patient have pockets \u2265 5 mm 6-8 weeks after phase I (non-surgical) therapy?\n\n#3: Does the patient have vertical 2 or 3 walls Intra-bony defects \u2265 3mm?\n\n#4: Is the patient able to come for follow-up appointments?\n\nPlease answer the questions with a \"yes\" or \"no\" and I will determine the patient's eligibility for the clinical trial.","PROBA":0.8877443392},{"ID":"33487_71-2021_NCT00938535","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9799342341},{"ID":"35338_75-2021_NCT00433654","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have, or is at risk of having, a heart beat that is too slow?\n\nYes, the patient has been diagnosed with Parkinson's disease, which can cause bradykinesia (slowness of movement) and tremors. This meets the inclusion criterion of having, or being at risk of having, a heart beat that is too slow.\n\n#2: Is the patient available for follow-up at the study center for the length of the study?\n\nYes, the patient is cooperative and does not have any signs of dementia, which suggests that they will be able to follow up with the study center for the length of the study.\n\n#3: Is the patient able and willing to undergo elective MRI scanning without sedation?\n\nNo, the patient is not able to undergo elective MRI scanning without sedation because they have a history of Parkinson's disease and tremors, which may make it difficult for them to remain still during the MRI scan. This meets the exclusion criterion of being unable to undergo MRI scanning without sedation.\n\nTherefore, based on the information provided, the patient is not eligible for the clinical trial.","PROBA":0.9235177048},{"ID":"17086_36-2021_NCT01981590","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of being older than 18 years of age and undergoing a cardiac catheterization involving right heart catheterization and\/or EP procedures and\/or device implant.\n\n#2. Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria of having a previously implanted transvenous lead, evidence of phrenic nerve palsy, chronic obstructive pulmonary disease, a spinal cord stimulator, or being pregnant, nursing, or of childbearing potential and not on a reliable form of birth control.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9389916723},{"ID":"35550_75-2021_NCT02476240","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease by a Neurologist. Therefore, this criterion is met.\n\n#2: Is the patient able to stand unassisted for 2 minutes?\n\nYes, the patient is able to stand unassisted for 2 minutes, as stated in the patient note. Therefore, this criterion is met.\n\n#3: Is the patient able to walk 10 meters unassisted?\n\nYes, the patient is able to walk 10 meters unassisted, as stated in the patient note. Therefore, this criterion is met.\n\n#4: Is the patient able to understand English instructions?\n\nYes, the patient is able to understand English instructions, as stated in the patient note. Therefore, this criterion is met.\n\n#5: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria listed in the patient note. Therefore, this criterion is met.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9369547165},{"ID":"5293_12-2021_NCT01302756","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a pregnant female (at least 18 years old) who is a Tricare Insurance Beneficiary receiving care at Nellis AFB. Therefore, the patient meets the inclusion criteria.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nThe patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, which may be considered a \"personal history of birth defects\" and could potentially make her ineligible for the study. However, the exclusion criteria state that patients with a personal history of neural tube defects are excluded, but do not specify any exclusions for other types of birth defects. Therefore, the patient's history of Marfan's syndrome and mitral valve prolapse may not be an exclusion criterion for the study.\n\nAdditionally, the patient is taking no medications that would make her ineligible for the study, and she does not have any of the other exclusion criteria listed (diagnosed as being diabetic, diagnosed with chronic hypertension prior to pregnancy, unable to communicate, non-English speaking, or a known seizure disorder or on anti-seizure medication).\n\nTherefore, based on the information provided, the patient would likely be considered eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9010548776},{"ID":"27599_40-2022_NCT01190150","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a history of at least one year of cyclic heavy menstrual bleeding?\n\nYes, the patient has a history of heavy menstrual bleeding for more than a year, which meets the inclusion criterion.\n\n#2: Does the patient report regularly occurring menstrual periods \u226410 days in duration, with 21-45 days from the start of one period to the start of the next menstrual period?\n\nYes, the patient reports regularly occurring menstrual periods that are \u226410 days in duration, which meets the inclusion criterion.\n\n#3: Does the patient have a diagnosis of heavy menstrual bleeding based on the medical judgment of the Principal Investigator?\n\nYes, the patient has a diagnosis of heavy menstrual bleeding based on the medical judgment of the Principal Investigator, which meets the inclusion criterion.\n\n#4: Is the patient either sexually inactive (abstinent) or using one of the following acceptable birth control methods and agree to continue its use throughout the study?\n\nYes, the patient is sexually inactive (abstinent), which meets the inclusion criterion.\n\n#5: Does the patient have negative pregnancy test results?\n\nYes, the patient has negative pregnancy test results, which meets the inclusion criterion.\n\n#6: Has the patient legally authorized representative (e.g., parent, guardian) voluntarily signed a parental permission\/informed consent form (ICF), and the subject must sign an assent, before the conduct of any study procedure?\n\nNot applicable, as the patient is under 18 years old and does not have a legal guardian.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.","PROBA":0.9395849232},{"ID":"27628_40-2022_NCT01391052","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have heavy periods?\n\nYes, the patient has heavy menstrual cycles each month.\n\n#2: Is the patient between 18-45 years old?\n\nYes, the patient is 23 years old, which is within the age range of 18-45.\n\n#3: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the inclusion and exclusion criteria provided, the patient would be eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9060663609},{"ID":"5322_12-2021_NCT01740583","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a structurally normal mitral valve?\n\n#2: Does the patient have at least Grade 2 mitral regurgitation?\n\n#3: What is the patient's left ventricular ejection fraction?\n\n#4: What is the patient's left ventricular end diastolic diameter?\n\nPlease answer each question with either \"eligible\" or \"not eligible\" based on the patient's information and the inclusion criteria for the clinical trial. Then, I will provide the final answer and explain the reasoning.","PROBA":0.8606120163},{"ID":"27738_40-2022_NCT02304510","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the age criteria?\n\n#2: Does the patient meet the residency criteria?\n\n#3: Does the patient meet the menstrual cycle criteria?\n\n#4: Does the patient meet the hormone therapy criteria?\n\n#5: Does the patient meet the hysterectomy criteria?\n\n#6: Does the patient meet the breastfeeding criteria?\n\n#7: Does the patient meet the pregnancy criteria?\n\nPlease answer each question with either \"yes\" or \"no\" and I will determine the patient's eligibility based on your answers.","PROBA":0.8684813724},{"ID":"27672_40-2022_NCT01769820","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have prolonged oral bleeding?\n\nYes, the patient has prolonged oral bleeding after a tooth extraction.\n\n#2: Does the patient have heavy menstrual cycles?\n\nYes, the patient has heavy menstrual cycles each month.\n\n#3: Does the patient have any other medical problems?\n\nNo, the patient does not have any other medical problems.\n\n#4: Does the patient take any medications?\n\nNo, the patient does not take any medications.\n\n#5: Does the patient have a family history of excessive bleeding?\n\nYes, the patient's mother and grandmother have also had excessive bleeding during menstrual periods.\n\nBased on the patient's information, she meets the inclusion criteria for the clinical trial:\n\n* Complaint of HMB (prolonged oral bleeding and heavy menstrual cycles)\n* Pre-menopausal\n* Age 18 years and over\n* Describing menstrual cycles every 21-42 days\n* Willing to practice a non-hormonal method of contraception for the duration of the study or have a partner with a vasectomy\n\nThe patient does not meet any of the exclusion criteria. Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9345082531},{"ID":"17312_36-2021_NCT03720392","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\n\nThe patient is 32 years old, which is within the age range of 18-80 years old specified in the inclusion criteria. Therefore, the patient meets the age criterion.\n\n#2: Gender\n\nThe patient is a woman, which is within the gender range of both men and women specified in the inclusion criteria. Therefore, the patient meets the gender criterion.\n\n#3: Body Mass Index (BMI)\n\nThe patient's BMI is 41.54, which is outside the normal range of 18.5-30 specified in the exclusion criteria. Therefore, the patient does not meet the BMI criterion.\n\n#4: Medical History\n\nThe patient has a history of sleep apnea, polycystic ovary syndrome (PCO), and dissatisfaction with her body shape, which are all within the scope of the inclusion criteria. However, the patient does not have a history of prior pregnancies, which is a requirement for inclusion in the study. Therefore, the patient does not meet the medical history criterion.\n\n#5: Current Health Status\n\nThe patient has a current health status of obese, which is within the scope of the inclusion criteria. However, the patient has a history of sleep apnea, which is not specified in the inclusion criteria. Therefore, the patient does not meet the current health status criterion.\n\nBased on the above analysis, the patient does not meet the inclusion criteria for the clinical trial. Therefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9166882504},{"ID":"6752_15-2021_NCT01774162","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a detectable lesion?\n\nYes, the patient has a detectable lesion based on the CT abdomen without contrast showing a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass.\n\n#2. Is the lesion inaccessible to EUS-guided biopsy?\n\nNo, the lesion is accessible to EUS-guided biopsy.\n\n#3. Does the patient require tissue sampling?\n\nYes, the patient requires tissue sampling for the diagnosis and staging of pancreatic adenocarcinoma.\n\n#4. Is the patient's lesion predominantly cystic?\n\nNo, the lesion is not predominantly cystic based on the CT scan showing a heterogeneous left upper abdominal mass.\n\n#5. Does the patient have coagulopathy with a known clotting factor deficiency or an uncorrectable INR > 1.5, PTT > 40, platelet count < 50,000?\n\nNo, the patient does not have coagulopathy based on the laboratory results.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9422525259},{"ID":"27979_40-2022_NCT03844776","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the age criteria?\n\n#2: Does the patient need surgical teeth extraction?\n\n#3: Is the patient willing to take part in the study?\n\n#4: Does the patient have any allergies to the study medication?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question. Once you have answered all questions, I will provide the final eligibility status.","PROBA":0.8172480974},{"ID":"27939_40-2022_NCT03585712","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have prolonged oral bleeding immediately after a tooth extraction?\n\nYes, the patient does have prolonged oral bleeding immediately after a tooth extraction.\n\n#2: Does the patient have heavy menstrual cycles each month?\n\nYes, the patient does have heavy menstrual cycles each month.\n\n#3: Does the patient have any other medical problems or take any medications?\n\nNo, the patient does not have any other medical problems or take any medications.\n\n#4: Does the patient have a history of excessive bleeding during menstrual periods?\n\nYes, the patient does have a history of excessive bleeding during menstrual periods.\n\n#5: Does the patient meet the inclusion criteria for the clinical trial?\n\nYes, the patient meets the inclusion criteria for the clinical trial.\n\n#6: Does the patient have any exclusion criteria for the clinical trial?\n\nNo, the patient does not have any exclusion criteria for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9337230986},{"ID":"35732_75-2021_NCT04051125","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2. Does the patient meet the inclusion criteria for the clinical trial?\n\nYes, the patient meets the inclusion criteria for the clinical trial, which are:\n\n* Parkinson's disease\n\n#3. Does the patient meet any of the exclusion criteria for the clinical trial?\n\nNo, the patient does not meet any of the exclusion criteria for the clinical trial, which are:\n\n* Age < 18 years\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9241060803},{"ID":"6744_15-2021_NCT01710254","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have persistent or paroxysmal atrial fibrillation?\n\nYes, the patient has persistent atrial fibrillation.\n\n#2. Does the patient have suspected coronary artery disease?\n\nYes, the patient has a history of coronary artery disease with a recent CT scan showing a large heterogeneous left upper abdominal mass consistent with pancreatic adenocarcinoma at the head of the pancreas.\n\n#3. Is the patient undergoing catheterization X-ray angiography?\n\nNo, the patient has already undergone CT scan without contrast, and the results showed a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass consistent with pancreatic adenocarcinoma at the head of the pancreas.\n\n#4. Does the patient have any contraindications to MRI?\n\nYes, the patient has a history of CAD and is currently being treated with IV antibiotics (Zosyn, then ceftriaxone and flagyl) and will continue on them until seen by ID as an outpatient, which may be a contraindication to MRI.\n\n#5. Is the patient over 60 or have any suspicion of abnormal kidney function?\n\nYes, the patient is over 60 years old and has a history of chronic kidney disease (SCr 2.1 in [**3-17**]).\n\nBased on the above criteria, the patient is not eligible for the clinical trial because of the contraindication to MRI and the history of chronic kidney disease. Therefore, the answer is [B: excluded].","PROBA":0.929594311},{"ID":"14175_30-2021_NCT03372772","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have primary hypothyroidism?\n\nYes, the patient has primary hypothyroidism.\n\n#2. Does the patient have fatigue symptoms?\n\nYes, the patient complains of fatigue, weight gain, and abnormal spotting between menses.\n\n#3. Is the patient receiving Levothyroxine treatment for at least 6 months?\n\nYes, the patient has been receiving Levothyroxine treatment for at least 6 months.\n\n#4. What is the patient's serum free thyroxine level?\n\nThe patient's serum free thyroxine level is within the normal range (0.80-1.80 ng\/dl).\n\n#5. What is the patient's serum Thyroid-stimulating hormone level?\n\nThe patient's serum Thyroid-stimulating hormone level is within the normal range (0.35-5.50 \u00b5IU\/ml).\n\n#6. Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the criteria provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9405836084},{"ID":"27533_40-2022_NCT00663481","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the age criteria?\n\nNo, the patient is 23 years old, which is outside the age range of 18-65 inclusive. Therefore, the patient does not meet the age criteria and is not eligible for the clinical trial.\n\n#2: Does the patient meet the gender criteria?\n\nYes, the patient is a female, which is within the gender criteria of the clinical trial.\n\n#3: Does the patient meet the body mass index (BMI) criteria?\n\nNo, the patient's body weight of 45-95 kg is outside the BMI range of 18 to 30 kg\/m2. Therefore, the patient does not meet the BMI criteria and is not eligible for the clinical trial.\n\n#4: Does the patient meet the smoking criteria?\n\nYes, the patient is a nonsmoker, which meets the smoking criteria of the clinical trial.\n\n#5: Does the patient meet the clinical criteria?\n\nNo, the patient has a history of prolonged oral bleeding, which may be a clinically significant illness and may interfere with the subject's safety during the study. Therefore, the patient does not meet the clinical criteria and is not eligible for the clinical trial.\n\nBased on the above assessment, the patient is not eligible for the clinical trial. Therefore, the answer is [B] Excluded.","PROBA":0.9248164416},{"ID":"30799_65-2021_NCT02770443","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have dilated cardiomyopathy (DCM)?\n\nNo, the patient does not have DCM.\n\n#2: Does the patient have recovered LV function to > or = to 50% documented on 2 ECHO examinations?\n\nNo, the patient does not have recovered LV function.\n\n#3: Is the time from initial diagnosis of DCM more or equal to 24 months?\n\nNo, the patient does not meet this criterion.\n\n#4: Has the patient had a last hospitalization for decompensated HF > 1 year ago?\n\nNo, the patient does not meet this criterion.\n\nBased on the information provided, the patient is not eligible for the clinical trial. Therefore, the answer is B: Excluded.","PROBA":0.9183277195},{"ID":"17418_36-2021_NCT04599803","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is within the age range of 18-65 years required for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: Legal Resident\nThe patient is a legal resident of the United States with a government-issued ID, which meets the inclusion criterion.\n\n#3: Smartphone and Computer Requirements\nThe patient owns a smartphone with a data plan and is the primary user of the smartphone, which meets the inclusion criterion. The patient also owns a computer with a web camera, which is not a specific inclusion criterion but is required for the study.\n\n#4: Access to Electricity and WiFi\nThe patient has consistent access to electricity and WiFi for the duration of the study, which meets the inclusion criterion.\n\n#5: Risk of OSA\nThe patient has a high risk of OSA as determined by a screening questionnaire, which meets the inclusion criterion.\n\n#6: Good Candidate for PAP Therapy\nThe patient is a good candidate for PAP therapy, in the opinion of the managing clinician, which meets the inclusion criterion.\n\n#7: No Significant Limitation\nThe patient does not have a significant limitation in ability to participate in the study, in the opinion of the investigator, which meets the inclusion criterion.\n\nBased on the above evaluation, the patient is eligible for the clinical trial. Therefore, the answer is [A: eligible].","PROBA":0.9318301358},{"ID":"7089_15-2021_NCT04704466","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have cancer of the upper aero-digestive tract?\n\nBased on the patient note, the patient has been diagnosed with pancreatic adenocarcinoma, which is not a type of cancer of the upper aero-digestive tract. Therefore, the patient does not meet the inclusion criterion #1 and is not eligible for the clinical trial.\n\nSo, the final answer is:\n\nB: Excluded","PROBA":0.8655228944},{"ID":"14148_30-2021_NCT03096613","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have subclinical hypothyroidism?\n\nYes, the patient has subclinical hypothyroidism, as evidenced by her high TSH level (13 mU\/L) and low free T4 level (0.2 ng\/dl).\n\n#2. Does the patient have chronic heart failure (CHF)?\n\nYes, the patient has CHF, as evidenced by her symptoms of fatigue, weight gain, and abnormal spotting between menses, and her diagnosis of Hashimoto's thyroiditis.\n\n#3. Is the patient aged 18 years or older?\n\nYes, the patient is aged 33 years old, which is within the inclusion criteria of 18 years or older.\n\n#4. Has the patient received standard HF therapy for at least 2 weeks?\n\nYes, the patient has received standard HF therapy for at least 2 weeks, as evidenced by her treatment with Levothyroxine.\n\n#5. Is the patient willing to provide informed consent?\n\nYes, the patient is willing to provide informed consent, as evidenced by her participation in the clinical trial.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9249301383},{"ID":"5533_12-2021_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient over 18 years old?\n\nYes, the patient is over 18 years old.\n\n#2. Does the patient have severe MR as read on a transthoracic echocardiographic study?\n\nYes, the patient has severe MR.\n\n#3. Is the mitral leaflet coaptation surface sufficient to reduce mitral regurgitation without undue leaflet tension?\n\nYes, the mitral leaflet coaptation surface is sufficient to reduce mitral regurgitation without undue leaflet tension.\n\n#4. Does the patient have degenerative mitral valve disease with mid-segment P2 prolapse?\n\nYes, the patient has degenerative mitral valve disease with mid-segment P2 prolapse.\n\n#5. Is the patient able to sign informed consent and able to return for follow-up?\n\nYes, the patient is able to sign informed consent and able to return for follow-up.\n\n#6. Is the patient capable of participating in all testing associated with this clinical investigation?\n\nYes, the patient is capable of participating in all testing associated with this clinical investigation.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9522217435},{"ID":"35817_75-2021_NCT04750226","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2. Is the patient's disease considered advanced?\n\nYes, the patient's disease is considered advanced.\n\n#3. Has the patient completed the parent study (M15-736)?\n\nYes, the patient has completed the parent study.\n\n#4. Is the patient considered an unsuitable candidate to receive ABBV-951 for any reason?\n\nNo, the patient is not considered an unsuitable candidate.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9165087333},{"ID":"35318_75-2021_NCT00220272","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient male or female?\n\nThe patient is male.\n\n#3: Is the patient over the age of 35?\n\nYes, the patient is over the age of 35.\n\n#4: Does the patient have a duration of the disease of less than 3 years since diagnosis?\n\nYes, the patient has a duration of the disease of less than 3 years since diagnosis.\n\n#5: Is the patient optimized on monotherapy by levodopa or a dopamine agonist?\n\nYes, the patient is optimized on monotherapy by levodopa or a dopamine agonist.\n\n#6: Does the patient have any indication of forms of parkinsonism other than PD?\n\nNo, there is no indication of forms of parkinsonism other than PD.\n\n#7: Does the patient have severe resting tremor, presence of either dyskinesia, fluctuations, or loss of postural reflexes?\n\nNo, the patient does not have severe resting tremor, presence of either dyskinesia, fluctuations, or loss of postural reflexes.\n\n#8: Is the patient taking any medications that are exclusion criteria?\n\nNo, the patient is not taking any medications that are exclusion criteria.\n\n#9: Does the patient have dementia, uncontrolled depression, psychotic disorder, or a history of substance-related disorders including alcohol or other substance use disorders?\n\nNo, the patient does not have dementia, uncontrolled depression, psychotic disorder, or a history of substance-related disorders including alcohol or other substance use disorders.\n\n#10: Does the patient have any clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial?\n\nNo, the patient does not have any clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nTherefore, the answer is:\n\nA: Eligible","PROBA":0.9640367185},{"ID":"17337_36-2021_NCT03958487","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a chronic DCA (more than 3 months)?\n\n#2: Does the patient have cognitive deficits relative to executive\/monitoring functions and\/or memory?\n\n#3: Is the patient at least 18 years old?\n\nPlease answer with A, B, or C for each question.\n\nA: Yes, the patient has a chronic DCA (more than 3 months).\n\nB: Yes, the patient has cognitive deficits relative to executive\/monitoring functions and\/or memory.\n\nC: Yes, the patient is at least 18 years old.\n\nPlease select one of the following options based on the answers:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease select one of the following options based on the answers:\n\nA: Eligible\nB: Excluded\nC: Irrelevant","PROBA":0.916048978},{"ID":"7000_15-2021_NCT03955081","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have small bowel disease indicated for deep enteroscopy?\n\nYes, the patient has a history of pancreatic adenocarcinoma at the head of the pancreas, which is a type of small bowel disease.\n\n#2. Is the patient at least 18 years old?\n\nYes, the patient is 70 years old, which is above the age of 18.\n\n#3. Is the patient not of child-bearing age and not currently pregnant or planning to become pregnant within the study period?\n\nYes, the patient is a 70-year-old woman, so she is not of child-bearing age.\n\n#4. Does the patient not have any contraindication to standard enteroscopy?\n\nThe patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, but these conditions do not appear to be contraindications to standard enteroscopy.\n\nTherefore, based on the information provided, the patient would likely be considered eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9429869429},{"ID":"35694_75-2021_NCT03793491","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Does the patient have motor fluctuations and\/or disabling dyskinesia?\n\nYes, the patient is experiencing motor fluctuations and disabling dyskinesia.\n\n#3: Is the patient in need of a second-line treatment?\n\nYes, the patient is in need of a second-line treatment.\n\n#4: Is the patient able to give informed consent?\n\nYes, the patient is able to give informed consent.\n\n#5: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the inclusion and exclusion criteria provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9407425231},{"ID":"30459_65-2021_NCT00466713","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have nonischemic dilated cardiomyopathy?\n\nYes, the patient has a diagnosis of nonischemic dilated cardiomyopathy.\n\n#2: Is the patient currently experiencing NYHA class I-II congestive heart failure?\n\nYes, the patient is currently experiencing NYHA class I-II congestive heart failure.\n\n#3: Has the patient had a stable comprehensive heart failure regimen for at least 3 months?\n\nYes, the patient has been on a stable comprehensive heart failure regimen for at least 3 months.\n\n#4: Is the patient's ejection fraction \u2264 40%?\n\nYes, the patient's ejection fraction is \u2264 40%.\n\n#5: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the criteria provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.930454933},{"ID":"30469_65-2021_NCT00539448","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes?\n\nYes, the patient has type 1 diabetes, as confirmed by molecular analysis 7 years ago.\n\n#2: Is the patient newly diagnosed with type 1 diabetes?\n\nNo, the patient has had type 1 diabetes for 7 years. Therefore, they do not meet the inclusion criterion of being newly diagnosed.\n\n#3: Is the patient treated with basal-bolus regimen including 3 or more injections of Regular Human Insulin per day?\n\nYes, the patient is treated with basal-bolus regimen including 3 or more injections of Regular Human Insulin per day.\n\n#4: Is the patient's BMI between 26-40 kg\/m2?\n\nYes, the patient's BMI is 28 kg\/m2, which is within the inclusion criteria range of 26-40 kg\/m2.\n\n#5: What is the patient's HbA1c level?\n\nThe patient's HbA1c level is 6.5%, which is within the inclusion criteria range of 7.5%-10%.\n\n#6: Does the patient have a median 2-hour postprandial glucose level of at least 140 mg\/dl (7.8 mmol\/L)?\n\nYes, the patient has a median 2-hour postprandial glucose level of 140 mg\/dl (7.8 mmol\/L), which meets the inclusion criteria.\n\n#7: Does the patient have a fasting plasma glucose level of at least 120 mg\/dl (6.7 mmol\/L)?\n\nYes, the patient has a fasting plasma glucose level of 120 mg\/dl (6.7 mmol\/L), which meets the inclusion criteria.\n\n#8: Is the patient willing and able to inject insulin Glargine therapy?\n\nYes, the patient is willing and able to inject insulin Glargine therapy, as stated in the inclusion criteria.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9581571385},{"ID":"6689_15-2021_NCT01250574","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a suspected infection in the GI tract or after abdominal surgery?\n\nYes, the patient has a suspected infection in the GI tract (abdominal mass, fevers, rigors, and bandemia) after abdominal surgery. Therefore, the patient meets the inclusion criteria.\n\n#2. Is the patient at least 18 years old?\n\nNo, the patient is 70 years old, which is less than 18 years old. Therefore, the patient does not meet the exclusion criteria.\n\nBased on the information provided, the patient is eligible for the clinical trial.","PROBA":0.9091323723},{"ID":"13995_30-2021_NCT01054443","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have immune thrombocytopenia (ITP)?\n\nYes, the patient has ITP based on the symptoms of fatigue, weight gain, and abnormal spotting between menses, which are consistent with ITP.\n\n#2: Is the patient > 18 years old?\n\nYes, the patient is 33 years old, which is greater than 18 years old.\n\n#3: Does the patient have a platelet count < 30,000\/\u03bcL if not taking medications or < 50,000\/\u03bcL despite concomitant steroids or other ITP therapies?\n\nYes, the patient has a platelet count of 20,000\/\u03bcL, which is less than 30,000\/\u03bcL if not taking medications.\n\n#4: Is the patient receiving stable dosages of cyclosporine A, mycophenolate mofetil, azathioprine, or danazol?\n\nNo, the patient is not receiving any of these medications.\n\n#5: Has the patient had a diagnostic bone marrow aspiration?\n\nYes, the patient has had a diagnostic bone marrow aspiration.\n\n#6: Is the patient willing and able to use barrier contraception?\n\nYes, the patient is willing and able to use barrier contraception.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9382032472},{"ID":"13964_30-2021_NCT00531713","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hypothyroidism?\n\nYes, the patient has been diagnosed with hypothyroidism.\n\n#2: Is the patient's TSH level > 20 at diagnosis?\n\nYes, the patient's TSH level is 13 mU\/L, which is above the inclusion criterion of > 20.\n\n#3: Is the patient's Anti-TPO level > 300?\n\nYes, the patient's Anti-TPO level is 120 IU\/ml, which is above the inclusion criterion of > 300.\n\n#4: Has the patient been on stable T4-substitution therapy for 6 months?\n\nNo, the patient has only been on Levothyroxine for a month, so they do not meet this inclusion criterion.\n\n#5: Are there any exclusion criteria that the patient does not meet?\n\nNo, the patient does not meet any of the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9352917608},{"ID":"17141_36-2021_NCT02450097","TOPIC_YEAR":2021,"RESPONSE":"#1. Age: The patient is 32 years old, which is greater than 18 years old, the minimum age requirement for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2. BMI: The patient's BMI is 41.54, which is greater than 23-37, the inclusion criteria for subjects without diabetes. However, the patient does not meet the exclusion criterion of BMI below 23. Therefore, the patient meets the BMI inclusion criterion.\n\n#3. Waist Circumference: The patient's waist circumference is not provided. However, based on the exclusion criterion of waist circumference 80 cm or less for women and 94 cm or less for men, it is likely that the patient would not meet this criterion.\n\n#4. Total Fat Percentage: The patient's total fat percentage is not provided. However, based on the exclusion criterion of total fat percentage less than 23%, it is likely that the patient would not meet this criterion.\n\n#5. Diabetes Status: The patient does not have diabetes, which meets the inclusion criterion for subjects without diabetes.\n\n#6. Other Inclusion Criteria: The patient does not have any of the other exclusion criteria, such as treatment with insulin and sulfonylurea drugs, chronic kidney disease (CKD) stage 4 and 5 (eGFR <30 ml\/min), pregnancy, breast-feeding, active athletes, or history of eating disorder.\n\nBased on the above criteria, the patient would likely be considered eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.928845348},{"ID":"27610_40-2022_NCT01261936","TOPIC_YEAR":2022,"RESPONSE":"#1. Age: The patient is 23 years old, which is within the inclusion criteria age range of 18-45 years. Therefore, the patient meets the age criterion.\n\n#2. Diagnosis: The patient has a diagnosis of congenital bleeding disorder, specifically von Willebrand disease. This meets the inclusion criterion of having an ascertained diagnosis of one of the following inherited bleeding disorders.\n\n#3. Bleeding Severity: The patient has a bleeding severity score of >2, which meets the inclusion criterion of having a bleeding severity score >2.\n\n#4. Signing the Consent Form: The patient has signed the consent form, which meets the inclusion criterion of signing the consent form.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9143672494},{"ID":"16975_36-2021_NCT01013207","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the following options based on your assessment:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide a brief explanation for your selection.","PROBA":0.8404306252},{"ID":"5548_12-2021_NCT04571372","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of age \u2265 19 yrs and severe aortic stenosis or severe aortic regurgitation.\n\n#2. Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria of pre-existing acute kidney injury, pre-existing end stage kidney disease, or life expectancy < 12 months.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the answer is:\n\nA. Eligible","PROBA":0.9070480136},{"ID":"6716_15-2021_NCT01476995","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have any of the qualifying medical diagnoses?\n\nNo, the patient does not have any of the qualifying medical diagnoses listed in the inclusion criteria.\n\n#2. Is the patient free from active medical diagnoses affecting the systems or organs listed in the inclusion criteria?\n\nNo, the patient has a recent history of abdominal mass with fevers\/rigors and bandemia, which suggests an active infection or inflammatory process affecting the abdominal organs.\n\n#3. Is the patient willing and able to provide informed consent?\n\nNo, the patient is not willing and able to provide informed consent because they are currently being treated for an active infection and are not in a condition to provide informed consent.\n\nTherefore, based on the inclusion and exclusion criteria provided, the patient is not eligible for the clinical trial.","PROBA":0.8899599943},{"ID":"35649_75-2021_NCT03416452","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\n\nThe patient is 55 years old, which is within the age range of 18-80 years old specified in the inclusion criteria. Therefore, the patient meets the age criterion.\n\n#2: Clinical diagnosis of Parkinson disease\n\nThe patient has been clinically diagnosed with Parkinson's disease by a neurologist, which meets the inclusion criterion.\n\n#3: Hoehn and Yahr stage\n\nThe patient's Hoehn and Yahr stage is II-III, which falls within the stage II-III range specified in the inclusion criteria. Therefore, the patient meets the Hoehn and Yahr stage criterion.\n\n#4: Other exclusion criteria\n\nThe patient does not have any of the exclusion criteria listed, such as a MoCA score of less than 25 within the last 6 months, uncontrolled medical condition, peripheral neuropathy, current or recent orthopedic disorder, current uncontrolled depression or major depressive episode, gait disorders other than PD, inability to walk safely without corrective lenses and without support, or a history of deep brain stimulation surgery.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9247742855},{"ID":"33917_71-2021_NCT04299100","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have chronic non-cancer pain for > 3 months?\n\nYes, the patient has chronic non-cancer pain for > 3 months.\n\n#2: Does the patient report sleep disturbances such as difficulty falling asleep, staying asleep, or problems waking up too early?\n\nYes, the patient reports sleep disturbances such as difficulty falling asleep and staying asleep.\n\n#3: Is the patient 18 years or older?\n\nYes, the patient is 18 years or older.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nTherefore, the answer is:\n\nA: Eligible.","PROBA":0.8925293282},{"ID":"5410_12-2021_NCT02771275","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have severe mitral regurgitation?\n\nYes, the patient has severe mitral regurgitation, which meets the inclusion criterion.\n\n#2: Is the patient referred for mitral valve surgery?\n\nYes, the patient is referred for mitral valve surgery, which meets the inclusion criterion.\n\n#3: Is the patient > 18 years old?\n\nYes, the patient is > 18 years old, which meets the inclusion criterion.\n\n#4: Does the patient have degenerative mitral valve disease?\n\nYes, the patient has degenerative mitral valve disease, which meets the inclusion criterion.\n\n#5: Is the patient able to sign informed consent and able to return for follow-up?\n\nYes, the patient is able to sign informed consent and able to return for follow-up, which meets the inclusion criterion.\n\n#6: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the information provided, the patient would be considered eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9440992966},{"ID":"14092_30-2021_NCT02393183","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mild TED of less than 18 months duration?\n\n#2: Is the patient euthyroid?\n\n#3: Is the patient between 18-70 years old?\n\nPlease select one of the following options based on the patient's information:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease select one of the following options based on the patient's information:\n\nA: Eligible\nB: Excluded\nC: Irrelevant","PROBA":0.8781077526},{"ID":"5435_12-2021_NCT03154034","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have symptomatic severe mitral regurgitation?\n\nYes, the patient has symptomatic severe mitral regurgitation.\n\n#2: Is the patient referred for diagnostic work-up and heart team discussion?\n\nYes, the patient is referred for diagnostic work-up and heart team discussion.\n\n#3: Has the patient declared informed consent?\n\nNo, the patient has not declared informed consent.\n\nBased on the criteria, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.898411184},{"ID":"17184_36-2021_NCT02723617","TOPIC_YEAR":2021,"RESPONSE":"#1. Check if the patient's BMI is within the inclusion criteria range of 20-40 kg\/m2.\n\nYes, the patient's BMI is 32, which is within the inclusion criteria range.\n\n#2. Check if the patient is a non-smoker.\n\nYes, the patient is a non-smoker.\n\n#3. Check if the patient's fasting glucose is \u2264 126 mg\/dl.\n\nYes, the patient's fasting glucose is 98 mg\/dl, which is within the inclusion criteria range.\n\n#4. Check if the patient has any exclusion criteria.\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the answer is: A. Eligible.","PROBA":0.9141327923},{"ID":"6963_15-2021_NCT03559348","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have cyto-\/histologically confirmed, recurrent or metastatic adenocarcinoma of the pancreas?\n\nYes, the patient has cyto-\/histologically confirmed, recurrent or metastatic adenocarcinoma of the pancreas.\n\n#2. Does the patient have disease measurable or evaluable on x-ray, computed tomography scan, or physical examination?\n\nYes, the patient has disease measurable or evaluable on x-ray, computed tomography scan, or physical examination.\n\n#3. Has the patient had prior chemotherapy for metastatic pancreatic cancer?\n\nNo, the patient has not had prior chemotherapy for metastatic pancreatic cancer.\n\n#4. Has the patient had prior radiotherapy?\n\nYes, the patient has had prior radiotherapy.\n\n#5. Is the patient willing to have an indwelling venous catheter implanted?\n\nYes, the patient is willing to have an indwelling venous catheter implanted.\n\n#6. Is the patient of reproductive potential and willing to use an effective contraceptive method?\n\nNo, the patient is not of reproductive potential.\n\n#7. Has the patient been informed of the investigational nature of this study and signed written informed consents?\n\nYes, the patient has been informed of the investigational nature of this study and has signed written informed consents.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9565656256},{"ID":"17047_36-2021_NCT01624155","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age criteria?\n\n#2: Does the patient meet the gender criteria?\n\n#3: Does the patient meet the ethnic background criteria?\n\n#4: Does the patient meet the health status criteria?\n\n#5: Does the patient meet the sexual activity criteria?\n\n#6: Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9832689009},{"ID":"35581_75-2021_NCT02768896","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\n#2: Is the patient ambulatory?\n\n#3: Can the patient sign a written informed consent?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.8357750631},{"ID":"35822_75-2021_NCT04784585","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 55 years old, which is within the inclusion criteria age range of 18-70 years. Therefore, the patient meets the age inclusion criterion.\n\n#2: BMI\nThe patient has a BMI of 32.8, which is within the inclusion criteria range of 25-50 kg\/m-squared. Therefore, the patient meets the BMI inclusion criterion.\n\n#3: Cardiovascular disease risk factors\nThe patient has hypertension and hypercholesterolemia, which are both cardiovascular disease risk factors. Therefore, the patient meets the inclusion criterion for having at least one cardiovascular disease risk factor.\n\n#4: Walking ability\nThe patient is able to walk 2 city blocks without stopping, which meets the inclusion criterion of being able to walk 2 city blocks without stopping.\n\n#5: Other exclusion criteria\nThe patient does not meet any of the exclusion criteria, such as currently participating in another weight loss program, currently taking weight loss medication, lost > 5% of their body weight in the 6 months prior to enrolling, has been pregnant within the 6 months prior to enrolling, plans to become pregnant within 6 months of enrolling, has chest pain during periods of activity or rest, or loss of consciousness in the 12 months prior to enrolling, has any medical condition that would affect the safety of participating in unsupervised physical activity, has history of bariatric surgery, or has any condition that would result in inability to follow the study protocol, including terminal illness, substance abuse, eating disorder (not including Binge Eating Disorder), or untreated major psychiatric illness.\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9540744273},{"ID":"33481_71-2021_NCT00909766","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have obesity?\n\nYes, the patient has obesity, as her BMI is 41.5, which is well above the upper limit of the normal range (18.5-24.9).\n\n#2: Is the patient of childbearing potential?\n\nNo, the patient is not of childbearing potential since she is postmenopausal.\n\n#3: Does the patient have any clinically significant medical conditions that could potentially affect her participation in the study and\/or personal well-being?\n\nNo, the patient does not have any clinically significant medical conditions that could potentially affect her participation in the study and\/or personal well-being.\n\n#4: Has the patient used any oral, injectable, or implantable hormonal contraceptive agents within 3 months prior to randomization?\n\nNo, the patient has not used any oral, injectable, or implantable hormonal contraceptive agents within 3 months prior to randomization.\n\n#5: Has the patient used any prescription drugs, over-the-counter medications, or herbal preparations within 1 week prior to randomization?\n\nYes, the patient has used over-the-counter medications (for example, Prevacid, Mylanta, or Rolaids) within 4 weeks prior to randomization.\n\n#6: Has the patient taken St. John's Wort within 1 week prior to randomization?\n\nNo, the patient has not taken St. John's Wort within 1 week prior to randomization.\n\n#7: Has the patient taken any investigational drug or placebo (inactive drug) within 4 weeks prior to randomization?\n\nNo, the patient has not taken any investigational drug or placebo (inactive drug) within 4 weeks prior to randomization.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial. The answer is A: eligible.","PROBA":0.9390254932},{"ID":"30522_65-2021_NCT01005303","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have New York Heart Association (NYHA) Class II or III heart failure?\n\n#2: Is the patient already on or tried on best known medical treatment (ACE inhibitor and beta-blocker)?\n\n#3: Is the patient stable for a period of at least 6 weeks?\n\n#4: Does the patient have a left ventricular ejection fraction of less than or equal to 45%?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.9020119127},{"ID":"35656_75-2021_NCT03491111","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a stroke?\n\nYes, the patient has a stroke.\n\n#2. Is the patient capable of performing voluntary respiratory maneuvers?\n\nYes, the patient is capable of performing voluntary respiratory maneuvers.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.8807776668},{"ID":"33744_71-2021_NCT02910869","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria. The patient has completed the MOVE! program between 2006-2015 with attendance in at least 75% of classes for group A cohort or completed the MOVE! program from 2012-2015 with participation in >75% of activities for group B cohort.\n\n#2. Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria. The patient does not have a history of or current diagnosed DSM-IV-TR eating disorder (i.e., anorexia nervosa or bulimia nervosa) or any current compensatory behaviors (e.g., vomiting, laxative use, excessive exercise). The patient does not have prescription medication usage, other medical\/psychological conditions that could interfere with the physician's ability to assess the effect of the test results on weight loss. The patient does not have a history of bipolar disorder, organic brain syndromes, or hospitalization for any psychiatric disorder within the last 12 months. The patient is not currently participating in a weight loss program and\/or taking weight loss medication. The patient has not lost > 5% of body weight during the past 6 months and does not have a history of bariatric surgery.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the answer is: A. Eligible.","PROBA":0.9486449265},{"ID":"35748_75-2021_NCT04174729","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2. Is the patient right-handed?\n\nYes, the patient is right-handed.\n\n#3. Does the patient have preserved cognitive functions?\n\nYes, the patient does not have any signs of dementia and is alert and cooperative.\n\n#4. Is the patient within the age range specified in the inclusion criteria?\n\nYes, the patient is within the age range of 20-39 years old.\n\n#5. Does the patient have minimum grip strength as measured by the Jamar \u00ae dynamometer?\n\nNo, the patient does not have minimum grip strength as measured by the Jamar \u00ae dynamometer. The patient's grip strength is not specified in the patient note.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the inclusion criterion of having minimum grip strength as measured by the Jamar \u00ae dynamometer.\n\nTherefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9332991711},{"ID":"35491_75-2021_NCT01952678","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease or essential tremor?\n\nYes, the patient has been diagnosed with Parkinson's disease (PD).\n\n#2: Is the patient non-Caucasian?\n\nNo, the patient is Caucasian.\n\n#3: Does the patient have existing diagnostic-quality and interpretable DaTscan SPECT images of the brain?\n\nYes, the patient has existing diagnostic-quality and interpretable DaTscan SPECT images of the brain.\n\n#4: Is the patient matched by final clinical diagnosis, sex, and age (\u00b15 years) with a non-Caucasian participant?\n\nNo, the patient is not matched with a non-Caucasian participant.\n\nBased on the criteria, the patient is not eligible for the clinical trial because they are Caucasian and do not meet the matching criteria with a non-Caucasian participant.\n\nTherefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9341860146},{"ID":"35422_75-2021_NCT01246336","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\n#2: Is the patient's disease stage mild (Hoehn-Yahr Stage I)?\n\n#3: Does the patient have any signs of dementia?\n\n#4: Is the patient willing and able to participate in the study?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.8344153391},{"ID":"7018_15-2021_NCT04113499","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient at least 18 years old?\n\nYes, the patient is 70 years old, which is above the age of 18. Therefore, the patient meets this criterion.\n\n#2: Does the patient have a history of acute pancreatitis?\n\nYes, the patient has a history of acute pancreatitis, as confirmed by the presence of abdominal pain characteristic of acute pancreatitis, elevated serum lipase\/amylase, and characteristic radiological findings of acute pancreatitis on CT abdomen.\n\n#3: Is the patient able to undergo general anesthesia?\n\nYes, the patient is able to undergo general anesthesia, as there is no indication of any medical condition that would preclude them from doing so.\n\n#4: Does the patient have a necrotic collection diagnosed on MRI or CT abdomen\/pelvis?\n\nYes, the patient has a necrotic collection diagnosed on CT abdomen, which meets this criterion.\n\n#5: Is the necrotic collection amenable to EUS-guided drainage?\n\nYes, the necrotic collection is amenable to EUS-guided drainage, as it is visualized on EUS and can be drained through this procedure.\n\n#6: Is the patient suspected or confirmed to have an infected necrotic collection?\n\nYes, the patient is suspected to have an infected necrotic collection, as there is a presence of gas in the necrotic collection on cross-sectional imaging and positive culture of necrotic tissue obtained preprocedure or at first intervention.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9343878727},{"ID":"14186_30-2021_NCT03529630","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have inverted nipples?\n\nYes, the patient has inverted nipples, which meets the inclusion criterion #1.\n\n#2: Is the patient pregnant?\n\nNo, the patient is not pregnant. The inclusion criterion #2 requires pregnant women in their 37th week of gestation or more. Therefore, the patient does not meet this criterion.\n\n#3: Is the patient able to read and write?\n\nYes, the patient is able to read and write, which meets the inclusion criterion #3.\n\n#4: Does the patient have any medical conditions that could interfere with breastfeeding?\n\nNo, the patient does not have any medical conditions that could interfere with breastfeeding. Therefore, she meets the exclusion criterion #4.\n\n#5: Is the patient choosing artificial milk as her preferred infant nutrition?\n\nNo, the patient is not choosing artificial milk as her preferred infant nutrition. Therefore, she meets the exclusion criterion #6.\n\nBased on the above analysis, the patient is not eligible for the clinical trial because she is not pregnant. The inclusion criterion #2 requires pregnant women in their 37th week of gestation or more.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9435206511},{"ID":"14252_30-2021_NCT04249271","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of infertility?\n\n#2: Does the patient have known thyroidal function (TSH and anti-TPO) levels?\n\n#3: Does the patient have any other endocrine pathology (such as Addison or diabetes mellitus)?\n\n#4: Does the patient have any manifest thyroidal pathology (such as Graves disease)?\n\n#5: Is the patient contraindicated against pregnancy?\n\n#6: Has the patient experienced three or more miscarriages?\n\n#7: Is the patient a heavy smoker (20 cigarettes per day or more)?\n\nPlease answer the questions with a \"yes\" or \"no\" to determine if the patient is eligible for the clinical trial.","PROBA":0.9073115825},{"ID":"35513_75-2021_NCT02086825","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have cirrhosis of the liver?\n\nYes, the patient has cirrhosis of the liver based on biopsy or clinical and radiographic criteria.\n\n#2. Does the patient have acute renal failure?\n\nYes, the patient has acute renal failure (increase in baseline creatinine of 0.5mg\/dL to a value of >2.0 mg\/dL within 3 days).\n\n#3. Is the patient's renal function not improving after adequate fluid resuscitation?\n\nYes, the patient's renal function is not improving after adequate fluid resuscitation using either normal saline or blood products (25% salt poor albumin, fresh frozen plasma, or packed red blood cells).\n\n#4. Is the patient aged 18 years or older?\n\nYes, the patient is aged 18 years or older.\n\n#5. Is the patient able to provide informed consent?\n\nYes, the patient is able to provide informed consent (Grade 0 to 1 HE).\n\nTherefore, based on the inclusion and exclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9519563175},{"ID":"17430_36-2021_NCT04646252","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a history of coronary artery disease?\n\nNo, the patient does not have a history of coronary artery disease. Therefore, this exclusion criterion does not apply.\n\n#2. Does the patient have a history of peripheral arterial disease?\n\nNo, the patient does not have a history of peripheral arterial disease. Therefore, this exclusion criterion does not apply.\n\n#3. Does the patient have a history of heart failure?\n\nNo, the patient does not have a history of heart failure. Therefore, this exclusion criterion does not apply.\n\n#4. Does the patient have a history of stroke?\n\nNo, the patient does not have a history of stroke. Therefore, this exclusion criterion does not apply.\n\n#5. Does the patient have hepatic failure?\n\nNo, the patient does not have hepatic failure. Therefore, this exclusion criterion does not apply.\n\n#6. Does the patient have renal failure?\n\nNo, the patient does not have renal failure. Therefore, this exclusion criterion does not apply.\n\n#7. Does the patient have active neoplasia?\n\nNo, the patient does not have active neoplasia. Therefore, this exclusion criterion does not apply.\n\n#8. Is the patient's diabetes mellitus poorly controlled?\n\nNo, the patient's diabetes mellitus is not poorly controlled. Therefore, this exclusion criterion does not apply.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nTherefore, the answer is: A. Eligible.","PROBA":0.9593438874},{"ID":"25424_53-2021_NCT04490252","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of primary glomerulonephritis?\n\nYes, the patient has a history of primary glomerulonephritis.\n\n#2: Does the patient have an eGFR between 60 ml\/min and 30 ml\/min?\n\nYes, the patient's eGFR is between 60 ml\/min and 30 ml\/min.\n\n#3: Is the patient between 18 and 65 years old?\n\nYes, the patient is between 18 and 65 years old.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9296647006},{"ID":"28073_40-2022_NCT04526275","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient does not meet the inclusion criteria because she has a history of heavy menstrual cycles, which is not listed as an inclusion criterion. Additionally, she has a history of bruising, which may be excluded by the \"history of dermal sensitivity\" exclusion criterion.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nThe patient does meet one exclusion criterion: a history of heavy menstrual cycles.\n\nBased on the information provided, the patient would not be eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.8670156107},{"ID":"11929_17-2022_NCT04110015","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a diagnosis of retina, glaucoma, or neuroophthalmic disorders?\n\n#2: Is the patient able to comprehend instructions and perform visual fields?\n\n#3: Does the patient have normal eye exams?\n\nPlease select one of the following options to indicate the patient's eligibility for the clinical trial:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease select one of the following options to indicate the patient's eligibility for the clinical trial:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9757507413},{"ID":"14150_30-2021_NCT03103776","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the options in the bracket at the end of each question to indicate your answer.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9783057769},{"ID":"16918_36-2021_NCT00489333","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the following options:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide your answer.","PROBA":0.8031885084},{"ID":"23201_33-2022_NCT01080534","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a male who is 20 years old, which meets the inclusion criterion of being male.\n\n#2: Does the patient meet the age requirement?\n\nThe patient is 20 years old, which is within the age range of 18 to 55 years. Therefore, the patient meets the age requirement.\n\n#3: Does the patient meet the body weight requirement?\n\nThe patient's body weight is not specified in the patient note, so it is unclear whether the patient meets the body weight requirement.\n\n#4: Does the patient have any medical conditions that would exclude them from the study?\n\nThe patient has Marfan syndrome, which is not listed as an exclusion criterion. Therefore, the patient is eligible to participate in the study.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the answer is: {A: eligible}.","PROBA":0.8921470815},{"ID":"27614_40-2022_NCT01307007","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria. She is a female with a history of heavy uterine bleeding within the past 6 months, and her screening visit central laboratory hemoglobin level is < 12 g\/dL, indicating iron deficiency anemia.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria. She does not have a history of hypersensitivity reaction to any component of ferric carboxymaltose or iron dextran, and she does not have any of the other exclusion criteria listed.\n\nTherefore, based on the information provided, the patient would be eligible for the clinical trial.","PROBA":0.9165829728},{"ID":"5319_12-2021_NCT01719211","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mitral valve prolapse?\n\nYes, the patient has mitral valve prolapse.\n\n#2: Is the patient willing to undergo mitral valve repair\/replacement surgery?\n\nNo, the patient is not willing to undergo surgery.\n\n#3: Does the patient have other mitral valve diseases?\n\nNo, the patient does not have other mitral valve diseases.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the inclusion criteria of being willing to undergo mitral valve repair\/replacement surgery. Therefore, the answer is \"B: Excluded\".","PROBA":0.908176049},{"ID":"6908_15-2021_NCT03116360","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a suspected acute stress fracture of the lower extremity?\n\nYes, the patient has a suspected acute stress fracture of the lower extremity, so this criterion is met.\n\n#2: Is the patient age 14 years or older?\n\nYes, the patient is 70 years old, which is greater than or equal to 14 years old, so this criterion is met.\n\n#3: Has the patient had symptoms for less than 4 weeks?\n\nNo, the patient has had symptoms for more than 4 weeks, so this criterion is not met.\n\n#4: Has the patient had an x-ray ordered by a clinician?\n\nYes, the patient has had an x-ray ordered by a clinician, so this criterion is met.\n\n#5: Is the patient able to undergo MRI (implantable pacemaker or other device not compatible for MRI)?\n\nNo, the patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, which may preclude them from undergoing MRI, so this criterion is not met.\n\n#6: Does the patient have any previous diagnosis of acute stress fracture in the location of interest?\n\nNo, the patient does not have any previous diagnosis of acute stress fracture in the location of interest, so this criterion is met.\n\n#7: Has the patient had any previous XR or MRI obtained at an outside clinic\/facility prior to presentation?\n\nNo, the patient has not had any previous XR or MRI obtained at an outside clinic\/facility prior to presentation, so this criterion is met.\n\n#8: Does the patient have any previously implanted hardware (ex. orthopedic screws or plates) at the location of interest?\n\nNo, the patient does not have any previously implanted hardware at the location of interest, so this criterion is met.\n\n#9: Are the patient's symptoms less than 8 weeks old?\n\nNo, the patient's symptoms are more than 8 weeks old, so this criterion is not met.\n\n#10: Is the patient able to undergo diagnostic ultrasound?\n\nNo, the patient has a history of abdominal mass and recent abdominal pain, which may preclude them from undergoing diagnostic ultrasound, so this criterion is not met.\n\nBased on the criteria, the patient is not eligible for the clinical trial.","PROBA":0.9563128415},{"ID":"5501_12-2021_NCT03982017","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have acute decompensated heart failure?\n\nYes, the patient has acute decompensated heart failure.\n\n#2: Does the patient have left ventricular systolic or diastolic heart failure?\n\nYes, the patient has left ventricular systolic heart failure.\n\n#3: Does the patient own a smartphone with a data plan?\n\nNo, the patient does not own a smartphone with a data plan.\n\n#4: Is the patient being discharged to home?\n\nYes, the patient is being discharged to home.\n\n#5: Is the patient unable to provide consent or comply with the intervention?\n\nNo, the patient is able to provide consent and comply with the intervention.\n\n#6: Is the patient currently enrolled in a remote monitoring\/telehealth program?\n\nNo, the patient is not currently enrolled in a remote monitoring\/telehealth program.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9499661552},{"ID":"5247_12-2021_NCT00483236","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have symptomatic mitral regurgitation with left ventricular dysfunction (LVEF < or = 40%) on maximal medical therapy?\n\nYes, the patient has symptomatic mitral regurgitation with left ventricular dysfunction (LVEF of 65% on TTE) and is on maximal medical therapy. Therefore, this criterion is met.\n\n#2: Does the patient fulfill surgical criteria set by the 2006 ACC\/AHA guidelines for the management of patients with valvular heart disease?\n\nYes, the patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, which fulfills the surgical criteria set by the 2006 ACC\/AHA guidelines for the management of patients with valvular heart disease. Therefore, this criterion is also met.\n\nBased on the above, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9345662015},{"ID":"17258_36-2021_NCT03279432","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI of 41.54, which is considered obese?\n\n#2: Does the patient have any of the following conditions: sleep apnea, PCO, or dissatisfaction with body shape?\n\n#3: Is the patient a high-school teacher married for 5 years?\n\n#4: Does the patient not use any contraceptive methods for the past 4 months and have no prior pregnancies?\n\n#5: Does the patient not smoke or use any drugs?\n\n#6: Does the patient like to try diets and exercise to lose weight?\n\n#7: Does the patient have a normal cardiac assessment, normal joints and ROM, and no prior history of metabolic disturbances?\n\nPlease select one of the options below based on the patient's information and the inclusion and exclusion criteria for the clinical trial:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease select one of the options above based on the patient's information and the inclusion and exclusion criteria for the clinical trial.","PROBA":0.9120745166},{"ID":"33531_71-2021_NCT01206413","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a non-obese woman aged 25-45 years, which meets the inclusion criteria.\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not have physician-diagnosed thyroid disease or diabetes, and she is not menopausal, so she meets the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9124569332},{"ID":"17378_36-2021_NCT04279600","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a Body Mass Index (BMI) between 30 and 40 kg\/m\u00b2?\n\n#2. Is the patient sedentary?\n\n#3. Does the patient have any associated comorbidities?\n\n#4. Is the patient a woman?\n\n#5. Has the patient undergone bariatric surgery?\n\n#6. Does the patient have any medical impediment to the practice of physical exercise?\n\n#7. Does the patient have any history of cancer, metabolic disease, smoking, or alcoholism?\n\nPlease answer the questions with either \"yes\" or \"no\" and I will determine the patient's eligibility for the clinical trial based on the answers.","PROBA":0.8862023124},{"ID":"14029_30-2021_NCT01581463","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hypothyroid disease?\n\nNo, the patient does not have hypothyroid disease. In fact, she has been diagnosed with Hashimoto's thyroiditis, which is an autoimmune disease that can cause hypothyroidism. However, she is currently being treated with Levothyroxine and her symptoms have improved, so she does not meet the exclusion criteria for the clinical trial.\n\n#2: Is the patient a healthy adult?\n\nYes, the patient is a healthy adult. She does not have any other medical conditions that would preclude her from participating in the clinical trial.\n\n#3: Can the patient swallow tablets?\n\nYes, the patient can swallow tablets. She does not have any difficulty swallowing or other gastrointestinal issues that would prevent her from taking the study medication.\n\nTherefore, based on the inclusion and exclusion criteria for the clinical trial, the patient would be eligible to participate.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9285101543},{"ID":"17451_36-2021_NCT04848532","TOPIC_YEAR":2021,"RESPONSE":"#1. Age: The patient is 32 years old, which is within the inclusion criteria age range of 14 to 18 years. Therefore, the patient meets the age criterion.\n\n#2. BMI: The patient's BMI is 41.54, which is within the inclusion criteria range of the 85th to 99th percentiles for sex and age. Therefore, the patient meets the BMI criterion.\n\n#3. Living situation: The patient is living at home with a parent or guardian, which meets the inclusion criterion of having a parent or guardian who is willing to participate in the study.\n\n#4. Willingness to participate: The patient is willing to complete baseline assessment tasks and is willing to download an app to track food intake and complete surveys on the phone for two seven-day periods throughout the course of the study, which meets the willingness to participate criterion.\n\n#5. Location: The patient is located in the US and is willing\/able to participate in remote intervention and assessments, which meets the location criterion.\n\n#6. Medical and psychiatric conditions: The patient does not have any acute suicide risk, inability to engage in physical activity, diabetes, history of bariatric surgery, current medical or psychiatric condition that may pose a risk to the participant during intervention, cause a change in weight, or limit ability to comply with the program (such as bulimia nervosa, substance abuse disorder, psychosis, bipolar I disorder, and\/or any condition prohibiting physical activity). Therefore, the patient meets the medical and psychiatric conditions criterion.\n\n#7. Pregnancy: The patient is not pregnant or planning to become pregnant in the next 2 years, which meets the pregnancy criterion.\n\n#8. Recent medication changes: The patient has not recently begun or changed the dose of a medication that can cause significant change in weight, which meets the recent medication changes criterion.\n\n#9. Weight loss: The patient has not experienced weight loss \u2265 5% in the previous 6 months, which meets the weight loss criterion.\n\n#10. Other treatments: The patient is not currently participating in, or planning to begin in the next 16 months, another weight loss treatment or psychotherapy for binge eating and\/or weight loss, which meets the other treatments criterion.\n\n#11. Compensatory behaviors: The patient is not engaging in compensatory vomiting, other severe compensatory behaviors, or more than 12 of any compensatory behaviors in the previous 3 months, which meets the compensatory behaviors criterion.\n\nBased on the above evaluation, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.","PROBA":0.955580208},{"ID":"17018_36-2021_NCT01321034","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the age criteria?\n\nYes, the patient is between 18 and 80 years old, so she meets the age criteria.\n\n#2. Does the patient have hyperlipoproteinemia?\n\nNo, the patient does not have hyperlipoproteinemia. Her LDL cholesterol level is 130 mg\/dL, which is not within the specified range of 70-190 mg\/dL.\n\n#3. Does the patient have triglycerides within the specified range?\n\nNo, the patient's triglycerides level is 150 mg\/dL, which is above the specified range of <500 mg\/dL.\n\n#4. Does the patient have at least two Lp(a) determinations previous to the beginning of the study without differences >20% or >20 mg\/dL?\n\nNo, the patient does not meet this criterion.\n\n#5. Is the patient on lipid-lowering therapy or has she been on stable doses in the last 3 months?\n\nNo, the patient is not on lipid-lowering therapy and has not been on stable doses in the last 3 months.\n\nBased on the criteria, the patient is not eligible for the clinical trial.\n\nTherefore, the answer is:\n\nB: Excluded","PROBA":0.9177767457},{"ID":"17206_36-2021_NCT02896751","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have sleep apnea?\n\n#2: Is the patient on stable NIV settings for a minimum of 2 months?\n\n#3: Is the patient willing to use the customized sleep mask for about 6 months?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.819516946},{"ID":"35319_75-2021_NCT00228150","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient male or female?\n\nThe patient is male.\n\n#3: Is the patient over the age of 35?\n\nYes, the patient is over the age of 35.\n\n#4: Does the patient have a duration of the disease of less than 3 years since diagnosis?\n\nYes, the patient has a duration of the disease of less than 3 years since diagnosis.\n\n#5: Is the patient at modified Hoehn and Yahr stage 2.5 or less?\n\nYes, the patient is at modified Hoehn and Yahr stage 2.5 or less.\n\n#6: Is the patient untreated?\n\nNo, the patient is not untreated.\n\n#7: Does the patient have any indication of forms of parkinsonism other than PD?\n\nNo, the patient does not have any indication of forms of parkinsonism other than PD.\n\n#8: Does the patient have severe resting tremor?\n\nNo, the patient does not have severe resting tremor.\n\n#9: Does the patient have presence of either dyskinesia, fluctuations, or loss of postural reflexes?\n\nNo, the patient does not have presence of either dyskinesia, fluctuations, or loss of postural reflexes.\n\n#10: Is the patient taking any medications that are exclusion criteria?\n\nNo, the patient is not taking any medications that are exclusion criteria.\n\n#11: Does the patient have any other clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial?\n\nNo, the patient does not have any other clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9568414355},{"ID":"17236_36-2021_NCT03109834","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a BMI between 27.0 and 34.9 kg\/m\u00b2?\n\n#2. Does the patient have one of the following blood lipids: total cholesterol \u2265 200 mg\/dL, LDL-cholesterol \u2265 175 mg\/dL, HDL-cholesterol \u2264 50 mg\/dL, TG 150-400 mg\/dL?\n\n#3. Is the patient a woman, aged 18-60 years?\n\n#4. Does the patient have any of the exclusion criteria?\n\nPlease answer the questions with the following options:\n\nA. Yes\nB. No\nC. Not relevant\n\nLet's start!","PROBA":0.903812512},{"ID":"35503_75-2021_NCT01994343","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\nYes, the patient is a woman (INCLUSION CRITERIA #1) and has a clinical diagnosis of chronic pelvic pain (INCLUSION CRITERIA #2).\n\n#2. Does the patient meet the exclusion criteria?\n\nNo, the patient does not have a duration of pain less than 6 months (EXCLUSION CRITERIA #1) and is not pregnant in the last 12 months (EXCLUSION CRITERIA #2).\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9275764666},{"ID":"17124_36-2021_NCT02364037","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 32 years old, which is within the inclusion criteria age range of 14-45 years. Therefore, the patient meets the age criterion.\n\n#2: Desire for pregnancy\nThe patient does not desire pregnancy during the next 12 months, which meets the inclusion criterion #2.\n\n#3: Sexual activity\nThe patient is sexually active with a man within the past 6 months or intends to have sex with a man in the next 3 months, which meets the inclusion criterion #3.\n\n#4: Willingness to undergo informed consent\nThe patient is willing and able to undergo informed consent, which meets the inclusion criterion #5.\n\n#6: Not currently pregnant\nThe patient is not currently pregnant, which meets the inclusion criterion #7.\n\n#8: Current patient at Family Care Carondelet, Family Care Forest Park Southeast, or Memphis Health Center\nThe patient is a current patient at one of the specified clinics, which meets the inclusion criterion #8.\n\nSince all of the inclusion criteria are met, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9415018918},{"ID":"6901_15-2021_NCT03028181","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have acute pancreatitis?\n\nYes, the patient has acute pancreatitis based on the clinical symptoms, personal interview, and laboratory tests (elevated serum lipase or amylase).\n\n#2. Does the patient meet the inclusion criteria for the clinical trial?\n\nYes, the patient meets the inclusion criteria for the clinical trial because they have acute pancreatitis and are classified as such based on clinical symptoms and laboratory tests.\n\n#3. Does the patient have any exclusion criteria for the clinical trial?\n\nNo, the patient does not have any exclusion criteria for the clinical trial. They do not have any accompanied diseases, and they are not alcohol or drug abusers.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9039545376},{"ID":"35823_75-2021_NCT04796246","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\n#2: Is the patient's disease classified as mild (Hoehn-Yahr Stage I)?\n\n#3: Is the patient over 18 years old?\n\n#4: Does the patient reside in the city of Porto Alegre\/RS?\n\n#5: Has the patient signed an informed consent form?\n\nPlease answer these questions with a \"yes\" or \"no\" to determine the patient's eligibility for the clinical trial.","PROBA":0.9024146496},{"ID":"35638_75-2021_NCT03300193","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of Essential Tremor or Parkinson's Disease?\n\nYes, the patient has a diagnosis of Parkinson's disease.\n\n#2: Is the patient between 18 and 80 years old?\n\nYes, the patient is 55 years old, which is within the inclusion criteria age range.\n\n#3: Has the patient undergone the MRgFUS procedure?\n\nNo, the patient has not undergone the MRgFUS procedure. This is an exclusion criterion.\n\n#4: Is the patient able and willing to give consent and able to attend all study visits and radiologic follow-up examinations by MRI?\n\nYes, the patient is alert and cooperative, and there is no indication that they would be unable to attend study visits or follow-up examinations.\n\n#5: Does the patient have a history of unsatisfactory response to medical management?\n\nYes, the patient has a history of unsatisfactory response to medical management, as they have tried and failed at least one drug.\n\n#6: Is the patient taking stable doses of all medications for 30 days prior to study entry?\n\nNo, there is no indication that the patient is taking stable doses of all medications for 30 days prior to study entry. This is an exclusion criterion.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they have not undergone the MRgFUS procedure and are not taking stable doses of all medications for 30 days prior to study entry.","PROBA":0.9451242018},{"ID":"28050_40-2022_NCT04331405","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have acute spinal cord injury (first 3 days after trauma)?\n\nNo, the patient does not have acute spinal cord injury. Therefore, this patient does not meet the inclusion criteria.\n\n#2: Does the patient have contusion type of SCI (MRI-confirmed)?\n\nNo, the patient does not have contusion type of SCI. Therefore, this patient does not meet the inclusion criteria.\n\n#3: Is the patient a Russian citizen?\n\nNo, the patient is not a Russian citizen. Therefore, this patient does not meet the inclusion criteria.\n\n#4: Does the patient have informed consent understood and signed by the patient?\n\nNo, the patient does not have informed consent understood and signed by the patient. Therefore, this patient does not meet the inclusion criteria.\n\nBased on the information provided, the patient is not eligible for the clinical trial. Therefore, the answer is B: excluded.","PROBA":0.922578412},{"ID":"33641_71-2021_NCT02142257","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age criteria?\n\n#2: Does the patient meet the BMI criteria?\n\n#3: Does the patient have an eating disorder?\n\n#4: Does the patient have severe co-morbidity?\n\n#5: Has the patient failed to achieve weight loss with lifestyle changes or other conservative approaches?\n\nPlease answer each question with either \"yes\" or \"no\" and I will determine the patient's eligibility for the clinical trial based on your answers.","PROBA":0.8711618132},{"ID":"13968_30-2021_NCT00565864","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 33 years old, which is within the inclusion criteria age range of 20-75 years. Therefore, the patient meets the age criterion.\n\n#2: Primary hypothyroidism\nThe patient has primary hypothyroidism, which is an inclusion criterion.\n\n#3: Stable dose of L-T4 for > 3 months\nThe patient has been on a stable dose of L-T4 for more than 3 months, which is an inclusion criterion.\n\n#4: Documented elevated TSH off L-T4\nThe patient has a documented elevated TSH level while off L-T4, which is an inclusion criterion.\n\n#5: Normal TSH level on usual dose of L-T4\nThe patient has a normal TSH level on their usual dose of L-T4, which is an inclusion criterion.\n\n#6: No acute or chronic medical or psychiatric illnesses that affect thyroid function, mood or cognition\nThe patient does not have any acute or chronic medical or psychiatric illnesses that affect thyroid function, mood or cognition, which is an inclusion criterion.\n\n#7: No medication use that affects thyroid function, mood or cognition (oral contraceptives or estrogen therapy allowed)\nThe patient does not use any medications that affect thyroid function, mood or cognition, except for oral contraceptives or estrogen therapy, which is allowed.\n\n#8: Normal score on screening Mini-Mental State Exam (MMSE)\nThe patient has a normal score on the screening MMSE, which is an inclusion criterion.\n\n#9: Normal vision and hearing\nThe patient has normal vision and hearing, which is an inclusion criterion.\n\n#10: Non-smoker\nThe patient is a non-smoker, which is an inclusion criterion.\n\nTherefore, based on the inclusion and exclusion criteria provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9581145581},{"ID":"6561_15-2021_NCT00068575","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of pancreatic cancer?\n\nNo, the patient does not have a history of pancreatic cancer. Therefore, this criterion is not met.\n\n#2: Is the patient's primary cancer completely resected (R0 or R1)?\n\nYes, the patient's primary cancer is completely resected (R0 or R1). Therefore, this criterion is met.\n\n#3: Does the patient have postoperative (pre-treatment) CT scan without evidence of radiographically defineable residual primary\/metastatic disease or clinically significant post-surgical changes?\n\nNo, the patient does not have postoperative (pre-treatment) CT scan without evidence of radiographically defineable residual primary\/metastatic disease or clinically significant post-surgical changes. Therefore, this criterion is not met.\n\n#4: Has the patient completed staging studies within three weeks +\/- 3 days of protocol registration?\n\nNo, the patient has not completed staging studies within three weeks +\/- 3 days of protocol registration. Therefore, this criterion is not met.\n\n#5: Does the patient have adequate organ function?\n\nNo, the patient does not have adequate organ function (creatinine clearance rate < 60 ml\/min). Therefore, this criterion is not met.\n\n#6: Is the patient willing and able to practice adequate contraception?\n\nNo, the patient is not willing and able to practice adequate contraception. Therefore, this criterion is not met.\n\nBased on the criteria listed above, the patient is not eligible for the clinical trial. Therefore, the answer is [B: excluded].","PROBA":0.9367740602},{"ID":"5373_12-2021_NCT02361008","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have single IVSD indicated by TTE?\n\nYes, the patient has single IVSD indicated by TTE.\n\n#2: Does the patient have any concomitant cardiac malformation, serious arrhythmia or other important non-cardiac diseases?\n\nNo, the patient does not have any concomitant cardiac malformation, serious arrhythmia or other important non-cardiac diseases.\n\n#3: Is the defect size \u226410 mm?\n\nYes, the defect size is \u226410 mm.\n\n#4: Is the patient willing to undergo mitral valve repair\/replacement surgery?\n\nYes, the patient is willing to undergo mitral valve repair\/replacement surgery.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9335206086},{"ID":"28018_40-2022_NCT04082143","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient meet the age requirement?\n\nNo, the patient is 23 years old, which is below the age requirement of at least 18 years old. Therefore, the patient is not eligible based on this criterion.\n\n#2: Is the patient willing and able to provide informed consent?\n\nYes, the patient is willing and able to provide informed consent, as they are participating in the study and have given their consent. Therefore, the patient meets this criterion.\n\n#3: Does the patient need one implant to replace a missing tooth?\n\nYes, the patient has a missing tooth and needs an implant, which meets this criterion.\n\n#4: Does the patient have at least 20 teeth in good repair and occlusion?\n\nNo, the patient has a missing tooth and does not meet this criterion. Therefore, the patient is not eligible based on this criterion.\n\n#5: Does the patient have sufficient bone volume for dental implant placement without required bone augmentation?\n\nNo, the patient does not have sufficient bone volume for dental implant placement without required bone augmentation, which does not meet this criterion.\n\n#6: Has the site development (soft and\/or bone tissue) been performed at least 5 months before implant placement, when required?\n\nNo, the site development has not been performed at least 5 months before implant placement, which does not meet this criterion.\n\nBased on the criteria, the patient is not eligible for the clinical trial. Therefore, the answer is B: Excluded.","PROBA":0.9383934521},{"ID":"6654_15-2021_NCT00948142","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have acute bacterial skin-structure infection (ABSSI)?\n\nYes, the patient has acute bacterial skin-structure infection (ABSSI) based on the symptoms and signs of infection described in the patient note.\n\n#2: Does the patient have at least 3 of the following local and\/or systemic symptoms and\/or signs of infection?\n\nYes, the patient has at least 3 of the following local and\/or systemic symptoms and\/or signs of infection: fever, purulent or seropurulent drainage\/discharge, erythema, fluctuance, heat\/localized warmth, pain\/tenderness to palpation, swelling\/induration, regional lymph node swelling or tenderness, and bandemia.\n\n#3: Is the infection suspected to be caused, at least in part, by a gram-positive pathogen?\n\nYes, the infection is suspected to be caused, at least in part, by a gram-positive pathogen based on the patient's history of recent likely history of diverticulitis and the presence of a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass on CT abdomen without contrast.\n\n#4: Does the patient meet the inclusion criteria for the clinical trial?\n\nYes, the patient meets the inclusion criteria for the clinical trial, which includes a diagnosis of acute bacterial skin-structure infection (ABSSI) of no more than 7 days duration, suspected or proven to be caused, at least in part, by a gram-positive pathogen, and requires at least 10-14 days of antibacterial therapy.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.941966508},{"ID":"17048_36-2021_NCT01636492","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is a male, which meets the inclusion criterion of being a male healthy volunteer.\n\nThe patient's age is within the range of 18 to 60 years, which meets the inclusion criterion.\n\nThe patient's BMI is within the range of 19-35 kg\/m2, which meets the inclusion criterion.\n\nThe patient's supine blood pressure is within the normal range, which meets the inclusion criterion.\n\nThe patient's heart rate is >\/= 40, which meets the inclusion criterion.\n\nThe patient's QTcB is <450 ms, which meets the inclusion criterion.\n\nTherefore, the patient meets all the inclusion criteria.\n\n#2: Does the patient meet the exclusion criteria?\n\nThe patient does not have a history or evidence of any clinically significant disease or disorder, which does not meet the exclusion criterion.\n\nThe patient does not have clinically significant ECG abnormalities, which does not meet the exclusion criterion.\n\nThe patient is not positive for hepatitis B, hepatitis C, or HIV infection, which does not meet the exclusion criterion.\n\nThe patient has not had previous treatment with iron for iron deficiency anemia, which does not meet the exclusion criterion.\n\nThe patient is not a regular smoker, which does not meet the exclusion criterion.\n\nThe patient does not have a history of alcohol and\/or drug abuse or addiction within the last 2 years before study start, which does not meet the exclusion criterion.\n\nThe patient does not have any confirmed significant allergic reactions against any drug, or multiple allergies in the judgment of the investigator, which does not meet the exclusion criterion.\n\nThe patient has not participated in a clinical study with an investigational drug within the last three months prior to screening, which does not meet the exclusion criterion.\n\nThe patient does not have any condition or disease detected during the medical interview\/physical examination that would render the subject unsuitable for the study, place the subject at undue risk or interfere with the ability of the subject to complete the study in the opinion of the investigators or their designee, which does not meet the exclusion criterion.\n\nTherefore, the patient does not meet any of the exclusion criteria.\n\nBased on the above analysis, the patient is eligible for the clinical trial.\n\nSo, the answer is: A: eligible.","PROBA":0.9618223078},{"ID":"16869_36-2021_NCT00172523","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have oligomenorrhea or amenorrhea?\n\n#2: Does the patient have hyperandrogenism?\n\n#3: Does the patient have PCO by ultrasound?\n\n#4: Is the patient after menarche and before menopause?\n\nPlease answer each question with either \"yes\" or \"no\" and I will determine the patient's eligibility for the clinical trial based on the answers.","PROBA":0.871807679},{"ID":"35814_75-2021_NCT04730245","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\n#2: Is the patient's disease moderate to severe?\n\n#3: Does the patient have dyskinesia and\/or motor fluctuations?\n\n#4: Has the patient had an incomplete or poor response to adjustments in time and dose of levodopa and other anti-parkinsonian agents?\n\n#5: Is the patient aged 18 years or older?\n\nPlease answer these questions with a \"yes\" or \"no\" to determine if the patient is eligible for the clinical trial.","PROBA":0.9030734342},{"ID":"6718_15-2021_NCT01513421","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have an infected intra-abdominal collection requiring a percutaneous drainage?\n\nYes, the patient has an infected intra-abdominal collection (pancreatic adenocarcinoma at the head of pancreas) that requires a percutaneous drainage.\n\n#2: Is the patient over 18 years old?\n\nYes, the patient is over 18 years old.\n\n#3: Is the intra-abdominal collection >5 cm in diameter with signs of infection on imaging?\n\nYes, the intra-abdominal collection is >5 cm in diameter and there are signs of infection on imaging (CT abdomen without contrast showing a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass).\n\nTherefore, based on the inclusion criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9312686601},{"ID":"6986_15-2021_NCT03858192","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 70 years old, which is within the inclusion criteria age range of 70 years or older. Therefore, the patient meets the age criterion.\n\n#2: Medical Condition\nThe patient has a history of CAD, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia. These conditions are not explicitly listed as exclusion criteria, and some of them (such as hypertension and hyperlipemia) are actually listed as inclusion criteria. Therefore, the patient meets the medical condition criterion.\n\n#3: Emergency Admission\nThe patient was admitted to the hospital due to fevers\/rigors and bandemia, which meets the emergency admission criterion.\n\n#4: Elective Surgery\nThe patient is undergoing elective major colorectal surgery, which meets the elective surgery criterion.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible","PROBA":0.9046282801},{"ID":"14255_30-2021_NCT04263779","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is discharging from a Geisinger hospital (Geisinger Medical Center, Geisinger Wyoming Valley Medical Center, or Geisinger Community Medical Center) and is selected for discharge to a skilled nursing facility (SNF). Yes, the patient meets the inclusion criteria.\n\n#2: Does the patient meet any exclusion criteria?\n\nThe patient does not have any exclusion criteria.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.894653555},{"ID":"28077_40-2022_NCT04553172","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a family history of bleeding disorders?\n\n#2: Does the patient have a history of excessive bleeding?\n\n#3: Is the patient a member of the family being studied?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.8165751253},{"ID":"23681_33-2022_NCT04664478","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a genetic variant in one of the connective tissue target genes?\n\n#2: Is the variant of sufficient interest for focused study to the clinical research team?\n\n#3: Is the patient within the age range of 2 to 100 years old?\n\nPlease select one of the following options based on the patient's information:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide your answer.","PROBA":0.8806693998},{"ID":"35383_75-2021_NCT00865111","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a healthy, normal adult man who volunteers to participate?\n\nYes, the patient is a healthy, normal adult man who volunteers to participate. Therefore, the answer is A: eligible.\n\n#2: Is he 18-45 years of age, inclusive?\n\nNo, the patient is 55 years old, which is outside the age range of 18-45. Therefore, the answer is B: excluded.\n\n#3: Is his BMI between 19 and 30, inclusive?\n\nNo, the patient's BMI is not between 19 and 30. Therefore, the answer is B: excluded.\n\n#4: Is he considered reliable and capable of understanding his responsibility and role in the study?\n\nYes, the patient is considered reliable and capable of understanding his responsibility and role in the study. Therefore, the answer is A: eligible.\n\n#5: Has he provided written informed consent?\n\nYes, the patient has provided written informed consent. Therefore, the answer is A: eligible.\n\nBased on the criteria, the patient is not eligible for the clinical trial.","PROBA":0.9422731228},{"ID":"30493_65-2021_NCT00703989","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\nPlease select one of the following options:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease provide your answer.","PROBA":0.8133815793},{"ID":"35467_75-2021_NCT01648803","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have probable or definite idiopathic Parkinson's disease (PD)?\n\n#2: Is the patient's Hoehn-Yahr stage 2-4?\n\n#3: Does the patient have one or more of the following PD-associated motor impairments experienced in the week prior to enrollment?\n\n#4: Is the patient willing and able to provide informed consent?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.8718135516},{"ID":"35500_75-2021_NCT01991457","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have ALL in complete remission (CR)?\n\nAccording to the patient note, the patient has been diagnosed with Parkinson's disease, not ALL. Therefore, the patient does not meet this criterion.\n\n#2: Is the patient at least 40 years old?\n\nYes, the patient is 55 years old, which meets this criterion.\n\n#3: Does the patient have any comorbidities that preclude them from undergoing CyTBI conditioning regimen?\n\nNo, there is no information in the patient note about any comorbidities that would preclude the patient from undergoing CyTBI conditioning regimen.\n\n#4: Does the patient have a willing adult HLA-matched sibling or HLA-matched unrelated donor?\n\nNo, there is no information in the patient note about a willing adult HLA-matched sibling or HLA-matched unrelated donor.\n\nBased on the information provided in the patient note, the patient does not meet the inclusion criteria for the clinical trial. Therefore, the patient is not eligible for the clinical trial.","PROBA":0.926758628}]
